Document:

Employment, Confidentiality, Non-Competition & Severance Agreement

 Exhibit 10.8 
  
 EMPLOYMENT, CONFIDENTIALITY, NON-COMPETITION 
 AND SEVERANCE AGREEMENT 
  
 THIS EMPLOYMENT, CONFIDENTIALITY, NON-COMPETITION AND SEVERANCE AGREEMENT (the “Agreement”) dated as of October 27, 2003 is made and entered into by and between AmericasDoctor, Inc., a Delaware corporation
(the “Company”), and Dennis Cavender (the “Employee”). 
  
 WHEREAS, the Company wishes to retain the services of the Employee as a key employee of the Company who is expected to make major contributions to the short- and long-term profitability, growth and financial strength
of the Company; and 
  
 WHEREAS, Company and Employee believe that
it is in their respective best interests to enter into and deliver this Agreement; and 
  
 WHEREAS, the Employee acknowledges that in the course of his employment by the Company, he will or may have access to and become informed of the Company’s confidential information and will frequently come into
contact with the Company’s customers (including, without limitation, its investigative research sites) and accounts such that the Employee will influence the business and relationships between the Company and its customers and accounts; and

  
 WHEREAS, the Employee has agreed to certain confidentiality,
non-solicitation, non-competition, and severance agreements; and in consideration for such agreements, the Company has agreed to pay the Employee termination payments upon severance of the Employee’s employment hereunder; and 
  
 NOW, THEREFORE, the Company and the Employee agree as follows: 
  

	1.	Certain Defined Terms. In addition to terms defined elsewhere herein, the following terms have the following meanings when used in this Agreement with initial capital
letters: 

  

	 	(a)	“Board” means the Board of Directors of the Company. 

  

	 	(b)	“Cause,” when used in the phrase “for cause” or “without cause” means: 

  

	 	(i)	the willful and continued failure by Employee to substantially perform his duties hereunder (other than any such failure resulting from Employee’s incapacity due to
Disability); 

  

	 	(ii)	engagement by the Employee in misconduct or gross negligence which is materially injurious to the Company, monetarily or otherwise; 

  

	 	(iii)	a willful act by the Employee of dishonesty, fraud, embezzlement or theft in connection with his duties or in the course of his employment with the Company or any Subsidiary;

	 	(iv)	a willful appropriation of a material business opportunity of the Company or any Subsidiary, including securing any personal profit in connection with any transaction entered into
on behalf of the Company or any Subsidiary, and which appropriation causes the Company or any Subsidiary to incur ascertainable damages; 

  

	 	(v)	willful damage by the Employee to property of the Company or any Subsidiary; 

  

	 	(vi)	breach of Section 10, 11, or Section 12 hereof; 

  

	 	(vii)	material breach of this Agreement; 

  

	 	(viii)	the conviction of, or the entering of a guilty plea or plea of no contest with respect to, a felony involving fraud, theft or the equivalent thereof, or any other crime involving
fraud or theft (but in each case only if such fraud, theft or similar crime relates to the business of the Company or a Subsidiary) with respect to which imprisonment for more than one (1) year is a possible punishment. 

  

	 	(c)	“Disabled” means the Employee’s incapacity due to physical or mental condition to perform the essential functions of Employee’s duties, with or without
reasonable accommodation, on a full-time basis for six consecutive months unless the Employee returns to the full-time performance of the Employee’s duties for a period of at least three consecutive months no later than 30 days after the
Company has given the Employee a notice of termination. If the Employee disagrees with a determination to terminate him because the Company believes he is Disabled, the Company and the Employee, or in the event of the Employee’s incapacity to
designate a doctor, the Employee’s legal representative, together shall choose a qualified medical doctor who shall determine whether the Employee is Disabled. If the Company and the Employee cannot agree on the choice of a qualified medical
doctor, then the Company and the Employee each shall choose a qualified medical doctor and the two doctors together shall choose a third qualified medical doctor, who shall determine whether the Employee is Disabled. The determination of the chosen
qualified medical doctor as to whether the Employee is Disabled shall be binding upon the Company and the Employee unless such determination is clearly made in bad faith. 

  

	 	(d)	“Involuntary Termination” means the occurrence of any of the following: (i) the Company gives thirty (30) days written notice to the Employee that the Company intends to
terminate the Agreement, (ii) the Company reduces the Employee’s base salary as set forth in Section 4, unless such reduction in base salary is part of a reduction applicable generally to senior Employees of the Company, or (iii) unless
otherwise agreed by the Employee, the Company relocates the Employee or his offices or the principal place where he is required to perform his duties hereunder farther than 50 miles from Gurnee, Illinois or such other place as the Company’s
principal Employee offices may, from time to time, be located. 

  

 2 

	 	(e)	“Restricted Business” means (i) any business or division of a business which consists of providing services to investigative sites and to their customers in connection
with clinical research and development, patient recruitment and persistency, training and quality assurance for clinical research, (ii) any business or division of a business which provides marketing or clinical research services to pharmaceutical
companies, (iii) any business of a kind in whole or in part similar to that heretofore or hereafter engaged in by the Company or any Subsidiary, and (iv) any other principal line of business developed or acquired by the Company or its affiliates.

  

	 	(f)	“Subsidiary” means an entity in which the Company directly or indirectly beneficially owns 50% or more of the outstanding Voting Stock. 

  

	 	(g)	“Termination Date” means the date on which the Employee’s employment is terminated (the effective date of which shall be the date of termination).

  

	 	(h)	“Voluntary Termination” means the occurrence of any of the following: (i) the date thirty (30) days after the Employee gives written notice to the Company that the
Employee intends to terminate this Agreement or if later, the date specified in such written notice, (ii) the Employee dies or (iii) the Employee becomes Disabled. 

  

	 	(i)	“Voting Stock” means securities entitled to vote generally in the election of directors. 

  

	1.	Term. 

  

	 	(a)	This Agreement shall be for a term that commences on the date this Agreement is approved by the Board (“Effective Date”) and, subject to any benefit continuation
requirements of applicable laws, expires on the earliest of (i) an Involuntary Termination, or (ii) a Voluntary Termination. For purposes of this Agreement, any reference to the “term” of this Agreement includes the original term and any
extension thereof. 

  

	 	(b)	The provisions of Sections 10, 11, and 12 survive termination of this Agreement for any reason, unless otherwise agreed to in writing and signed by Employee and the Chief Executive
Officer of the Company. 

  

	2.	Employment. The Company hereby agrees to the employment of the Employee, and the Employee hereby agrees to be employed by the Company, upon the terms and conditions
herein set forth. 

  
 The Company agrees to maintain
adequate director and officer insurance to cover Employee at no additional cost to the Employee, and the Company will use best efforts to maintain such insurance at all times while this Agreement remains in effect. 
  

	3.	 Duties of the Employee. The Employee serves as the Company’s Chief Financial Officer. This Agreement survives a change in title or duties as
directed by the Board or 

  

 3 

 
CEO. The Employee reports directly to the Company’s Chief Executive Officer, or to another Corporate Officer as designated by the Board, and has such
duties as the Chief Executive Officer and the Board may from time to time prescribe. The Employee devotes his full time and best efforts to the Company’s business of providing services to investigative sites and to their customers in connection
with clinical research and development and any other related duties and responsibilities that may from time to time be prescribed by the Chief Executive Officer or the Board; so long as it does not interfere with the Employee’s employment
hereunder, the Employee may serve as an officer, director or otherwise participate in educational, welfare, social, religious and civic organizations. The Employee represents that he is not under a restrictive covenant, non-competition agreement,
confidentiality agreement or other agreement or obligation that might prohibit Employee from being employed by the Company or from performing the duties contemplated in this Section 3. 
  

	4.	Compensation. 

  
 The Employee will receive a gross base salary of $166,666.67 per annum, which base salary the Board may adjust from time to time, payable at the times and
in the manner consistent with the Company’s general policies regarding compensation of executive Employees. Such base salary includes any salary reduction contributions to (i) any Company-sponsored plan (the “401(k) Plan”) that
includes a cash-or-deferred arrangement under Section 401(k) of the Internal Revenue Code of 1986, as amended (the “Code”), (ii) any other Company-sponsored plan of deferred compensation or (iii) any Company-sponsored “cafeteria
plan” under Section 125 of the Code. 
  
 The Company also
agrees to pay Tatum CFO Partners, LTD. (“Tatum”) an amount of $2,777.78 on a monthly basis while the Employee is employed with the Company according to the terms and conditions of the “Resources Agreement” between Tatum and the
Company (Exhibit A). 
  

	5.	Benefits. The Company shall make available to the Employee, subject to the terms and conditions of the applicable plans, including without limitation the eligibility
rules, participation for the Employee and his eligible dependents in the Company-sponsored employee benefit plans or arrangements and such other usual and customary benefits now or hereafter generally available to employees of the Company and such
benefits and perquisites as may be from time to time made available to Employees of the Company. 

  
 Should the Employee waive participation in the health insurance plans, an amount equal to the Company’s monthly contribution will be paid to the
Employee on a monthly basis. 
  

	6.	Expenses. The Company shall pay or reimburse the Employee, in accordance with the general policies of the Company, for reasonable and necessary expenses incurred by
the Employee in connection with his duties on behalf of the Company. 

  

	7.	Place of Performance. In connection with his employment by the Company, unless otherwise agreed by the Employee, the Employee shall be based at offices located in
Gurnee, Illinois or, at the Company’s request, such other place as the Company’s principal Employee offices may, from time to time, be located, except for travel reasonably required for Company business. 

  

 4 

	8.	Termination Payments, Vesting and Exercise of Stock Options upon Involuntary Termination other than for Cause or Voluntary Termination due to Death or Disability.

  

	 	(a)	If an Involuntary Termination occurs other than for Cause and if the Executive enters into a release and settlement agreement with the Company, then 

  

	 	(i)	for a period of three (3) months thereafter (the “Payment Period”), the Company shall pay the Executive, in accordance with the Company’s regular payroll schedule,
termination payments that in the aggregate equal the one-fourth (1/4) the sum of the Executive’s highest annual base salary during the three-year period prior to the Executive’s termination. 

  

	 	(ii)	during the Payment Period, the Company shall (A) to the extent permitted under the 401(k) Plan, permit the Executive to continue to participate in the 401(k) Plan and receive the
maximum matching contribution thereunder as if such Involuntary Termination had not occured, or (B) if continued participation in the 401(k) Plan is not permitted under the 401(k) Plan, pay to the Executive an amount equal to the maximum matching
contribution to which he would have been entitled under the Company’s 401(k) Plan as if such Involuntary Termination had not occurred; and 

  

	 	(iii)	Executive shall have the right to exercise any and all vested stock options at any time not later than 90 days after the date of the Involuntary Termination.

  

	 	(b)	Notwithstanding anything to the contrary herein, any termination payments which the Executive becomes entitled to receive under Section 8(a) shall be reduced to the extent that the
Executive receives payments of severance compensation pursuant to Section 1 

  

	 	(c)	Any termination payments hereunder shall not be taken into account for purposes of any retirement plan or other benefit plan sponsored by the Company, except as otherwise set forth
herein or as expressly required by such plans or applicable law. 

  

	 	(d)	If a Voluntary Termination due to Executive’s death during the term of this Agreement occurs, then notwithstanding anything to the contrary in the Executive’s stock option
agreement(s) or certificate(s) or in the stock option plan(s) under which Executive’s stock options were granted, (i) one-third of the unvested portion of all stock options granted to Executive shall become immediately exercisable as of the
date of Executive’s death, and (ii) all other unvested stock options held by Executive shall be immediately canceled. Executive’s estate shall have a period of one year following Executive’s death to exercise any vested stock options.

  

 5 

	 	(e)	If a Voluntary Termination due to Executive’s becoming Disabled during the term of this Agreement occurs, then notwithstanding anything to the contrary in the Executive’s
stock option agreement(s) or certificate(s) or in the stock option plan(s) under which Executive’s stock options were granted, (i) one-third of the unvested portion of all stock options granted to Executive shall become immediately exercisable
as of the date of Disability, and (ii) all other unvested stock options held by Executive shall be immediately canceled. Executive shall have a period of one year following Executive’s Disability to exercise any vested stock options.

  

	 	(f)	If the Executive dies while any amounts are payable to him hereunder, all such amounts, unless otherwise provided herein, shall be paid to the Executive’s designated
beneficiary, or, if none, then to the Executive’s estate. 

  

	 	(g)	Notwithstanding the foregoing, if the Executive breaches Sections 10, 11 or 12 hereof, any right of the Executive to receive termination payments, to have the vesting of his options
accelerated or to have the period during which he may exercise his options extended under this Section 8 shall be forfeited, but without prejudice to any exercise of options that may have occurred prior to such forfeit, and the Executive shall
reimburse the Company in full for all termination payments made to the Executive under this Section 8 no later than 30 days after the Company gives notice of such breach to the Executive. 

  

	9.	Benefits Upon Termination. Employee and any dependents will have any conversion rights available under the health insurance plans and as otherwise provided by law,
including the Comprehensive Omnibus Budget Reconciliation Act (“COBRA”) effective the first of the month following the date of termination. Employee further agrees that on the first of the month following the date of termination, Employee
will be responsible for the full insurance premiums for COBRA coverage. 

  

	10.	Confidentiality Agreement. 

  

	 	(a)	The Employee acknowledges that in the course of his employment by the Company, he will or may have access to and become informed of confidential and secret information that
is a competitive asset of the Company (“Confidential Information”), including, without limitation, (i) the terms of agreements between the Company and its employees, customers (including, without limitation, its investigative research
sites) and suppliers, (ii) pricing strategy, (iii) sales and marketing methods, (iv) product development ideas and strategies, (v) personnel training and development programs, (vi) financial results, (vii) strategic plans and demographic analyses,
(viii) proprietary computer and systems software and (ix) any non-public information concerning the Company, its employees, suppliers and customers. Regardless of any actual or alleged breach by the Company of this Agreement, the Employee shall keep
all Confidential 

  

 6 

	 	 
Information in strict confidence and shall not directly or indirectly make known, divulge, reveal, furnish, make available or use any Confidential
Information (except in the course of his regular authorized duties on behalf of the Company) until and unless such Confidential Information becomes, through no fault of the Employee, generally known to the public or the Employee is required by law
to make disclosure (after giving the Company reasonable notice and an opportunity to contest such requirement). The Employee’s obligations under this Section 10 are in addition to, and not in limitation or preemption of, all other obligations
of confidentiality which the Employee may have to the Company under general legal or equitable principles. 

  

	 	(b)	Except in the ordinary course of the Company’s business, the Employee has not made and shall never make or cause to be made, any copies, pictures, duplicates, facsimiles
or other reproductions or recordings or any abstracts or summaries including or reflecting Confidential Information. All such documents and other property furnished to the Employee by the Company or otherwise acquired or developed by the Company
shall at all times be the property of the Company. Upon a Voluntary Termination or Involuntary Termination, the Employee shall return to the Company any such documents or other property of the Company which are in the possession, custody or control
of the Employee. 

  

	11.	Ownership of Inventions, Discoveries, Improvements, Etc. 

  

	 	(a)	Employee shall promptly disclose and describe to the Company all inventions, improvements, discoveries and technical developments, whether or not patentable, made or conceived by
Employee, either alone or with others, during the term of this Agreement and for a period of one (1) year following the Termination Date, and that (i) are based in whole or in part upon Confidential Information, or (ii) are along the lines of,
useful in or related to the Company’s business, or (iii) result from, or are suggested by, any work that may be done by Employee for or on behalf of the Company (“Inventions”). Employee hereby assigns and agrees to assign to the
Company Employee’s entire right, title and interest in and to such Inventions, and agrees to cooperate with the Company both during and after the term of this Agreement in the procurement and maintenance, at the Company’s expense and at
its direction, of patents, copyright registrations and/or protection of the Company’s rights in such Inventions. Employee shall keep and maintain adequate and current written records of all such Inventions, which shall be and remain the
property of the Company. 

  

	 	(b)	If a patent application or copyright registration is filed by Employee or on Employee’s behalf, or a copyright notice indicating Employee’s authorship is used by Employee
or on Employee’s behalf, within one (1) year after the Termination Date, that describes or identifies any Invention within the scope of Employee’s work for the Company or that otherwise related to a portion of the Company’s business
(or any division or Subsidiary thereof) of which Employee had knowledge during the term of this Agreement, it is to be conclusively presumed that the Invention was conceived by the Employee during the term of 

  

 7 

	 	 
this Agreement. Employee agrees to notify the Company promptly of any such application or registration and to assign to the Company Employee’s entire
right, title and interest in such Invention and in such application or registration. 

  

	 	(c)	There is no contract or duty on Employee’s part now is existence to assign Inventions except in favor of the Company. Employee shall not disclose or induce the Company to use
any confidential information that Employee is either now aware of, or shall become aware of, that belongs to a former employer or anyone other than the Company or a Subsidiary. 

  

	12.	Covenant not to Compete; No Inducement; No Solicitation. In consideration for the Employee’s employment hereunder and the Company’s providing the Employee
with confidential information and contacts with the Company’s customers and accounts, during the term of the Employment Provisions and for a period of one year after the Termination Date, 

  

	 	(a)	The Employee shall not, without the prior written consent of the Company (which consent may be withheld for any reason or no reason), directly or indirectly or by action in concert
with others, own, manage, operate, join, control, perform consulting services for, be employed by, participate in or be connected with any business, enterprise or other entity (or the ownership, management, operation, or control of any such
business, enterprise or other entity) (a “Competing Enterprise”) engaged anywhere in the United States or Canada in the Restricted Business. Notwithstanding the foregoing, Employee may make purely passive investments on behalf of himself,
his immediate family or any trust in public companies engaged in a Competing Enterprise so long as the aggregate interest represented by such investments does not exceed 1% of any class of the outstanding debt or equity securities of any Competing
Enterprise. 

  

	 	(b)	The Employee shall not, directly or indirectly, in any capacity, on his own behalf or on behalf of any other firm, person or entity, induce or attempt to induce any customer of the
Company (including, without limitation, any investigative research site) to cease doing business in whole or in part with the Company, solicit the business of any such customer for any Restricted Business or otherwise create any ill will or negative
publicity with respect to the Company. 

  

	 	(c)	The Employee shall not, directly or indirectly, in any capacity, on his own behalf or on behalf of any other firm, person or entity, undertake or assist in the solicitation of any
Company employee, including, without limitation, solicitation of any employee to terminate his or her employment with the Company. 

  
 Employee and the Company acknowledge that the nature of the foregoing prohibited activities is geographically broad as a result of the expansive
geographic scope of the Restricted Business and the national scope of Employee’s duties hereunder. 
  

	13.	Post-termination Assistance. Employee shall provide such information and assistance to the Company as the Company may reasonably request, upon reasonable notice, in

  

 8 

	 	 
connection with any litigation in which it or any of its affiliates is or may become a party. The Company shall reimburse the Employee for any expenses,
including travel expenses, incurred by the Employee in connection with providing such information and assistance. 

  

	14.	Withholding of Taxes. The Company may withhold from any amounts payable under this Agreement all federal, state, city or other taxes as the Company is required to
withhold pursuant to any law or government regulation or ruling. 

  

	15.	Specific Enforcement. The Employee acknowledges and agrees that a violation of Sections 10, 11 or 12 hereof that results in material detriment to the Company would
cause irreparable harm to the Company, and that the Company’s remedy at law for any such violation would be inadequate. In recognition of the foregoing, the Company shall have the right, in addition to any other relief afforded by law or this
Agreement, including damages sustained by a breach of this Agreement and any forfeitures under Section 8, and without any necessity or proof of actual damages, to enforce this Agreement by specific remedies, including, among other things, temporary
and permanent injunctions, it being the understanding of the Company and the Employee that damages, the forfeitures described above and injunctions shall all be proper modes of relief and shall not be considered alternative remedies.

  

	16.	Notices. For all purposes of this Agreement, all communications, including without limitation notices, consents, requests or approvals, required or permitted to be
given hereunder shall be in writing and shall be deemed to have been duly given when hand delivered or dispatched by electronic facsimile transmission (with receipt thereof confirmed), or five business days after having been mailed by United States
registered or certified mail, return receipt requested, postage prepaid, or three business days after having been sent by a nationally recognized overnight courier service (such as Federal Express or UPS) addressed to the Company (to the attention
of the Secretary of the Company) at its principal Employee office and to the Employee at his principal residence, or to such other address as either party may have furnished to the other in writing and in accordance herewith, except that notices of
changes of address shall be effective only upon receipt. 

  

	17.	Governing Law. The validity, interpretation, construction and performance of this Agreement shall be governed by and construed in accordance with the substantive laws
of the State of Illinois, without giving effect to the principles of conflict of laws of such State. 

  

	18.	Indemnification. The Company agrees to indemnify the Employee to the full extent permitted by law for any losses, costs, damages, and expenses, including reasonable
attorneys’ fees, as they are incurred, in connection with any cause of action, suit, or other proceeding arising in connection with Employee’s employment with the Company, including, but not limited to, indemnification for deductibles on
insurance policies. This indemnity will not apply to Employee’s gross negligence or willful misconduct or to actions taken by the Employee in bad faith. 

  

 9 

	19.	Agreement. This Agreement contains all of the covenants and agreements between the parties with respect to such subject matter. Each party to this Agreement
acknowledges that no representations, inducements, promises, or other agreements, orally or otherwise, have been made by any party, or anyone acting on behalf of any party, pertaining to the subject matter hereof, that are not embodied herein, and
that no other agreement, statement or promise pertaining to the subject matter hereof that is not contained in this Agreement shall be valid or binding on either party. 

  

	20.	Validity. If any provision of this Agreement or the application of any provision hereof to any person or circumstances is held invalid, unenforceable or otherwise
illegal, the remainder of this Agreement and the application of such provision to any other person or circumstances shall not be affected, and the provision so held to be invalid, unenforceable or otherwise illegal shall be reformed to the extent
(and only to the extent) necessary to make it enforceable, valid or legal. 

  

	21.	Miscellaneous. No provision of this Agreement may be modified, waived or discharged unless such waiver, modification or discharge is agreed to in writing signed by the
Employee and the Company. No waiver by either party hereto at any time of any breach by the other party hereto or compliance with any condition or provision of this Agreement to be performed by such other party shall be deemed a waiver of similar or
dissimilar provisions or conditions at the same or at any prior or subsequent time. Unless otherwise noted, references to “Sections” are to sections of this Agreement. The captions used in this Agreement are designed for convenient
reference only and are not to be used for the purpose of interpreting any provision of this Agreement. 

  

	22.	Counterparts. This Agreement may be executed in one or more counterparts, each of which shall be deemed to be an original but all of which together shall constitute
one and the same agreement. 

  

	23.	Effective Date. Notwithstanding anything to the contrary herein, this Agreement shall not become effective unless and until the Board approves this Agreement. Upon
receipt of such approval, this Agreement shall become immediately effective. 

  
 [Remainder of page intentionally left blank] 
  

 10 

 IN WITNESS WHEREOF, the Company and the Employee have executed this Agreement as of the date first above
written1. 
  

							
	 AMERICASDOCTOR.COM, INC.

				
	 	 	 /s/ C. Lee Jones

	 	 	 	 /s/ Dennis Cavender

	 By:
	 	 C. Lee Jones
	 	 By:
	 	 Dennis Cavender

	 Its:
	 	 Chief Executive Officer
	 	 Its:
	 	 Chief Financial Officer

  

	1	The validity of execution of this Agreement on behalf of the Company is subject to the approval of this Agreement by the Board. 

  

 11Amended & Restated Revolving Credit and Security Agreement

 Exhibit 10.11 
 AMENDED AND RESTATED REVOLVING CREDIT 
 AND SECURITY AGREEMENT 
  
 THIS AMENDED AND RESTATED REVOLVING CREDIT AND SECURITY AGREEMENT (the
“Agreement”) dated as of February 20, 2004, is entered into among AMERICASDOCTOR, INC., a Delaware corporation, and AMERICASDOCTOR.COM COORDINATOR SERVICES, INC., a Delaware corporation (individually and
collectively, the “Borrower”), and CAPITALSOURCE FINANCE LLC, a Delaware limited liability company (“Lender”). 
  
 WHEREAS, Lender and Borrower and AmericasDoctor Internet Operations, Inc. entered into that certain Revolving Credit and Security Agreement dated as of
March 15, 2002, as amended by that certain First Amendment to Revolving Credit and Security Agreement dated as of March 5, 2003, and as further amended by that certain Limited Waiver Second Amendment to Revolving Credit and Security Agreement dated
as of November 12, 2003 (collectively, the “Loan Agreement”), and related documents and instruments executed in connection therewith; 
  
 WHEREAS, Lender has agreed to continue to make available to Borrower a revolving credit facility (the “Revolving Facility”) in a maximum
principal amount at any time outstanding of up to Six Million Dollars ($6,000,000) (the “Facility Cap”), the proceeds of which shall be used by Borrower for refinancing Borrower’s existing obligations and indebtedness and
working capital needs; and 
  
 WHEREAS, Lender is willing to make
the Revolving Facility available to Borrower upon the terms and subject to the conditions set forth herein. 
  
 NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt and adequacy of which hereby are
acknowledged, Borrower and Lender hereby agree as follows: 
  
 I. DEFINITIONS

  
 1.1 General Terms 
  
 For purposes of this Agreement, in addition to the definitions above and
elsewhere in this Agreement, the terms listed in Appendix A hereto shall have the meanings given such terms in Appendix A, which is incorporated herein and made a part hereof. All capitalized terms used which are not specifically
defined shall have meanings provided in Article 9 of the UCC in effect on the date hereof to the extent the same are used or defined therein. Unless otherwise specified herein or in Appendix A, any agreement or contract referred to herein or
in Appendix A shall mean such agreement as modified, amended or supplemented from time to time. Unless otherwise specified, as used in the Loan Documents or in any certificate, report, instrument or other document made or delivered pursuant
to any of the Loan Documents, all accounting terms not defined in Appendix A or elsewhere in this Agreement shall have the meanings given to such terms in and shall be interpreted in accordance with GAAP. 

 II. ADVANCES, PAYMENT AND INTEREST 
  
 2.1 The Revolving Facility 
  

(a) Subject to the provisions of this Agreement, Lender shall make Advances to Borrower under the Revolving Facility from time to time during the Term;
provided that, notwithstanding any other provision of this Agreement, the aggregate amount of all Advances at any one time outstanding under the Revolving Facility shall not exceed either of (a) the Facility Cap and (b) the Availability as
defined below. The Revolving Facility is a revolving credit facility, which may be drawn, repaid and redrawn, from time to time as permitted under this Agreement. Unless otherwise permitted by Lender, each Advance shall be in an amount of at least
$1,000. Subject to the provisions of this Agreement, Borrower may request Advances under the Revolving Facility up to and including the value, in U.S. Dollars, of fifty percent (50%) of the Borrowing Base minus, if applicable, amounts reserved
pursuant to this Agreement (such calculated amount being referred to herein as the “Availability”). Advances under the Revolving Facility automatically shall be made for the payment of interest on the Note and other Obligations on
the date when due to the extent available and as provided for herein. 
  
 (b) Lender has established the above-referenced advance rate for Availability and, in its sole credit judgment, may further adjust the Availability and such advance rate by applying percentages (known as “liquidity factors”) to
Eligible Receivables based upon Borrower’s actual recent collection history in a manner consistent with Lender’s generally applicable underwriting practices and procedures, including without limitation Lender’s review and analysis of,
among other things, Borrower’s historical returns, rebates, discounts, credits and allowances (collectively, the “Dilution Items”). Such liquidity factors and the advance rate for Availability may be adjusted by Lender
throughout the Term as warranted in Lender’s sole credit judgment, consistent with Lender’s generally applicable underwriting practices and procedures. Also, Lender shall have the right to establish from time to time, in its sole credit
judgment, consistent with its generally applicable lending practices, reserves against the Borrowing Base, which reserves shall have the effect of reducing the amounts otherwise eligible to be disbursed to Borrower under the Revolving Facility
pursuant to this Agreement. 
  
 2.2 The Note; Maturity

  
 (a) All Advances under the Revolving Facility shall be
evidenced by a Note, payable to the order of Lender, duly executed and delivered by Borrower, evidencing the aggregate indebtedness of Borrower to Lender resulting from Advances under the Revolving Facility, from time to time. Lender hereby is
authorized, but is not obligated, to enter the amount of each Advance under the Revolving Facility and the amount of each payment or prepayment of principal or interest thereon in the appropriate spaces on the reverse of or on an attachment to the
Note. Lender will account to Borrower monthly with a statement of Advances under the Revolving Facility and charges and payments made pursuant to this Agreement, and in the absence of manifest error, such accounting rendered by Lender shall be
deemed final, binding and conclusive unless Lender is notified by Borrower in writing to the contrary within thirty (30) calendar days of Receipt of each accounting, which notice shall be deemed an objection only to items specifically objected to
therein. 
  
 (b) All amounts outstanding under the Note and other
Obligations shall be due and payable in full, if not earlier in accordance with this Agreement, on the earlier of (i) the occurrence of an Event of Default if required pursuant hereto or Lender’s demand upon an Event of Default, and (ii) the
last day of the Term (such earlier date being the “Maturity Date”). 
  
 2.3 Interest 
  
 Interest
on outstanding Advances under the Note shall be payable monthly in arrears on the first Business Day of each calendar month at an annual rate of Prime Rate plus 2.0%, provided, 
  

 2 

 however, that, notwithstanding any provision of any Loan Document, the interest on outstanding Advances under the
Note shall be not less than 7.5%, in each case calculated on the basis of a 360-day year and for the actual number of calendar days elapsed in each interest calculation period. Interest accrued on each Advance under the Note shall be due and payable
on the first day of each calendar month, in accordance with the procedures provided for herein, commencing the month immediately following the first Advance, and continuing until the later of the expiration of the Term and the full performance and
irrevocable payment in full in cash of the Obligations and termination of this Agreement. 
  
 2.4 Revolving Facility Disbursements; Requirement to Deliver Borrowing Certificate 
  
 So long as no Default or Event of Default shall have occurred and be continuing, Borrower may give Lender irrevocable written notice requesting an Advance
under the Revolving Facility by delivering to Lender not later than 11:00 a.m. (New York City time) at least two but not more than four Business Days before the proposed borrowing date of such requested Advance (the “Borrowing
Date”), a completed Borrowing Certificate and relevant supporting documentation reasonably satisfactory to Lender, which shall (i) specify the proposed Borrowing Date of such Advance which shall be a Business Day, (ii) specify the principal
amount of such requested Advance, and (iii) certify the matters contained in Section 4.2. Each time a request for an Advance is made, and, in any event and regardless of whether an Advance is being requested, on the last Business Day of each
week during the Term (and more frequently if Lender shall so request) until the Obligations are indefeasibly paid in cash in full and this Agreement is terminated, Borrower shall deliver to Lender a Borrowing Certificate as of the immediately
preceeding month end accompanied by a separate detailed aging and categorizing of Borrower’s accounts receivable and accounts payable and such other supporting documentation with respect to the figures and information in the Borrowing
Certificate as Lender shall reasonably request from a credit or security perspective or otherwise. On each Borrowing Date, Borrower irrevocably authorizes Lender to disburse the proceeds of the requested Advance to Borrower’s account(s) as set
forth on Schedule 2.4, in all cases for credit to Borrower (or to such other account as to which Borrower shall instruct Lender) via Federal funds wire transfer no later than 4:00 p.m. (New York City time). 
  
 2.5 Revolving Facility Collections; Repayment; Borrowing Availability and
Lockbox 
  
 Each Borrower shall maintain one or more lockbox
accounts (individually and collectively, the “Lockbox Account”) with one or more banks reasonably acceptable to Lender (each, a “Lockbox Bank”), and shall execute with each Lockbox Bank one or more agreements
reasonably acceptable to Lender (individually and collectively, the “Lockbox Agreement”), and such other agreements related thereto as Lender may reasonably require to perfect a security interest therein. Borrower shall ensure that
all collections of its Accounts and all other cash payments received by Borrower are paid and delivered directly from Account Debtors and other Persons into the appropriate Lockbox Account. The Lockbox Agreements shall provide that the Lockbox Banks
immediately will transfer all funds paid into the Lockbox Accounts into a depository account or accounts maintained by Lender or an Affiliate of Lender at such bank as Lender may communicate to Borrower from time to time (the “Concentration
Account”) or such other account as directed by Borrower in accordance with the terms and conditions of the Lockbox Agreement. Notwithstanding and without limiting any other provision of any Loan Document, Lender shall apply, on a daily
basis, all funds transferred into the Concentration Account pursuant to the Lockbox Agreement and this Section 2.5 in such order and manner as determined by Lender. To the extent that any Accounts collections of Borrower or any other cash
payments received by Borrower are not sent directly to the appropriate Lockbox Account but are 
  

 3 

 received by Borrower or any of their Affiliates, such collections and proceeds shall be held in trust for the benefit of
Lender and immediately remitted (and in any event within two (2) Business Days), in the form received, to the appropriate Lockbox Account for immediate transfer to the Concentration Account. Borrower acknowledges and agrees that compliance with the
terms of this Section 2.5 is an essential term of this Agreement. All funds transferred to the Concentration Account for application to the Obligations under the Revolving Facility shall be applied to reduce the Obligations under the
Revolving Facility, but, for purposes of calculating interest hereunder, shall be subject to a seven Business Day clearance period. If as the result of collections of Accounts and/or any other cash payments received by Borrower pursuant to this
Section 2.5 a credit balance exists with respect to the Concentration Account, such credit balance shall be immediately, and in any event within two (2) Business Days, transferred to an account designated by Borrower from time to time;
provided that each such transfer will not occur unless and until the earlier of (i) such additional amounts exceed $25,000, or (ii) Borrower’s written request for such transfer; and provided, further, that Lender shall have
the right in its sole discretion to apply collections and/or any cash payments to reduce the Loan balance to zero. If applicable, at any time prior to the execution of all or any of the Lockbox Agreements and operation of all or any of the Lockbox
Accounts, Borrower and their Affiliates shall direct all collections or proceeds it receives on Accounts or from other Collateral to the accounts(s) and in the manner specified by Lender in its reasonable discretion. 
  
 2.6 Promise to Pay; Manner of Payment 
  
 Borrower absolutely and unconditionally promises to pay principal, interest
and all other amounts payable hereunder, or under any other Loan Document, without any right of rescission and without any deduction whatsoever, including any deduction for any setoff, counterclaim or recoupment, and notwithstanding any damage to,
defects in or destruction of the Collateral or any other event, including obsolescence of any property or improvements. Any payments made by Borrower (other than payments automatically paid through Advances under the Revolving Facility as provided
herein), shall be made only by wire transfer on the date when due, without offset or counterclaim, in Dollars, in immediately available funds to such account as may be indicated in writing by Lender to Borrower from time to time. Any such payment
received after 2:00 p.m. (New York City time) on the date when due shall be deemed received on the following Business Day. Whenever any payment hereunder shall be stated to be due or shall become due and payable on a day other than a Business Day,
the due date thereof shall be extended to, and such payment shall be made on, the next succeeding Business Day, and such extension of time in such case shall be included in the computation of payment of any interest (at the interest rate then in
effect during such extension) and/or fees, as the case may be. 
  
 2.7 Repayment of Excess Advances 
  
 Any balance
of Advances under the Revolving Facility outstanding at any time in excess of the lesser of the Facility Cap or the Availability shall be immediately due and payable by Borrower without the necessity of any demand, at the Payment Office, whether or
not a Default or Event of Default has occurred or is continuing and shall be paid in the manner specified in Section 2.6.  
  
 2.8 Payments by Lender 
  
 Should any amount required to be paid under any Loan Document be unpaid for more than three (3) Business Days after the due date, such amount may be paid
by Lender, which payment shall be deemed a request for an Advance under the Revolving Facility as of the date such payment is due, and Borrower irrevocably authorizes disbursement of any such funds to Lender by way of direct 
  

 4 

 payment of the relevant amount, interest or Obligations. No payment or prepayment of any amount by Lender or any other
Person shall entitle any Person to be subrogated to the rights of Lender under any Loan Document unless and until the Obligations have been fully performed and paid irrevocably in cash and this Agreement has been terminated. Any sums reasonably
expended by Lender as a result of Borrower’s failure to pay, perform or comply with any Loan Document or any of the Obligations may be charged to Borrower’s account as an Advance under the Revolving Facility and added to the Obligations.

  
 2.9 Grant of Security Interest; Collateral 

 
 (a) To secure the payment and performance of the Obligations, Borrower
hereby grants to Lender a continuing first priority security interest (subject to Permitted Liens, which in no case shall include or permit liens on Accounts or proceeds thereof) in and Lien upon, and pledges to Lender, all of its right, title and
interest in and to the following (collectively and each individually, the “Collateral”): 
  
 (i) all of such Borrower’s tangible personal property, including without limitation all present and future Inventory and Equipment, now owned or
hereafter acquired; 
  
 (ii) all of such Borrower’s
intangible personal property, including without limitation all present and future Accounts, securities, contract rights, Permits, General Intangibles, Chattel Paper, Documents, Instruments and Deposit Accounts, Investment Property, Letter-of-Credit
Rights, Supporting Obligations, rights to the payment of money or other forms of consideration of any kind, tax refunds, insurance proceeds, now owned or hereafter acquired, and all intangible and tangible personal property relating to or arising
out of any of the foregoing; and 
  
 (iii) any and all additions
to any of the foregoing, and any and all replacements, products and proceeds (including insurance proceeds) of any of the foregoing. 
  
 (b) Notwithstanding the foregoing provisions of this Section 2.9, such grant of a security interest shall not extend to, and the term
“Collateral” shall not include, any General Intangibles of Borrower to the extent that (i) such General Intangibles are not assignable or capable of being encumbered as a matter of law or under the terms of any license or other agreement
applicable thereto (but solely to the extent that any such restriction shall be enforceable under applicable law) without the consent of the licensor thereof or other applicable party thereto, and (ii) such consent has not been obtained;
provided, however, that the foregoing grant of a security interest shall extend to, and the term “Collateral” shall include, each of the following: (a) any General Intangible which is in the nature of an Account or a right to
the payment of money or a proceed of, or otherwise related to the enforcement or collection of, any Account or right to the payment of money, or goods which are the subject of any Account or right to the payment of money, (b) any and all proceeds of
any General Intangible that is otherwise excluded to the extent that the assignment, pledge or encumbrance of such proceeds is not so restricted, and (c) upon obtaining the consent of any such licensor or other applicable party with respect to any
such otherwise excluded General Intangible, such General Intangible as well as any and all proceeds thereof that might theretofore have been excluded from such grant of a security interest and from the term “Collateral.” 
  
 (c) Upon the execution and delivery of this Agreement, and upon the proper
filing of the necessary financing statements, without any further action, Lender will have a good, valid first priority (subject to Permitted Liens, which in no case shall include or permit liens on Accounts or the proceeds thereof) Lien and
security interest in the Collateral, subject to no transfer or other restrictions or 
  

 5 

 Liens of any kind in favor of any other Person except for Permitted Liens. No financing statement relating to any of the
Collateral is on file in any public office except those (i) on behalf of Lender, and/or (ii) in connection with Permitted Liens.  
  
 2.10 Collateral Administration 
  
 (a) All Collateral (except Deposit Accounts) will at all times be kept by Borrower at the locations set forth on Schedule 5.18B hereto and shall
not, without thirty (30) calendar days prior written notice to Lender, be moved therefrom, and in any case shall not be moved outside the United States. 
  
 (b) Borrower shall keep commercially reasonable accurate and complete records of its Accounts and all payments and collections thereon and shall submit
such records to Lender on such periodic bases as Lender may reasonably request (but unless an Event of Default has occurred and is continuing, not more frequently than monthly). In addition, if (i) Accounts of Borrower in an aggregate face amount in
excess of $40,000 become ineligible because they fall within one of the specified categories of ineligibility set forth in the definition of Eligible Receivables and (ii) Borrower has borrowed fifty percent (50%) or more of its Availability and such
amount is currently outstanding, then Borrower shall notify Lender of such occurrence on the first Business Day following Borrower’s knowledge thereof and the Borrowing Base shall thereupon be adjusted to reflect such occurrence. If requested
by Lender after the occurrence and during the continuance of an Event of Default, Borrower shall execute and deliver to Lender formal written assignments of all of its Accounts weekly or daily as Lender may request, including all Accounts created
since the date of the last assignment, together with copies of claims, invoices and/or other information related thereto. To the extent that collections from such assigned accounts exceed the amount of the Obligations, such excess amount shall not
accrue interest in favor of Borrower, but shall be available to Borrower upon Borrower’s written request. 
  
 (c) Whether or not an Event of Default has occurred, any of Lender’s officers, employees, representatives or agents shall have the right, at any time
during normal business hours, in the name of Lender, any designee of Lender or Borrower, to verify the validity, amount or any other matter relating to any Accounts of Borrower which, prior to the occurrence or continuation of a Default or Event of
Default shall not include the right to contact Borrower’s customers or account debtors. Borrower shall cooperate fully with Lender in an effort to facilitate and promptly conclude such verification process. 
  
 (d) Lender shall have the right at all times after the occurrence and during
the continuance of an Event of Default to notify Account Debtors owing Accounts to Borrower that their Accounts have been assigned to Lender and to collect such Accounts directly in its own name and to charge collection costs and expenses, including
reasonable attorney’s fees, to Borrower. 
  
 (e) As and when
determined by Lender in its sole discretion, Lender will perform the searches described in clauses (i) and (ii) below against Borrower (the results of which are to be consistent with Borrower’s representations and warranties under this
Agreement) once per calendar quarter prior to the occurrence and continuation of any Default or Event of Default at Borrower’s expense, and following the occurrence and continuation of a Default or Event of Default, as often as Lender
reasonably shall deem appropriate, all at Borrower’s expense: (i) UCC searches in the state of Borrower’s formation; and (ii) judgment, federal tax lien and corporate and partnership tax lien searches, in each jurisdiction searched under
clause (i) above. 
  

 6 

 (f) Borrower (i) shall provide prompt written notice to its current bank to transfer all items,
collections and remittances to the Concentration Account, (ii) shall provide prompt written notice to each Account Debtor to make payments to the appropriate Lockbox Account, and Borrower hereby authorizes Lender, upon any failure to send such
notices and directions within ten (10) calendar days after the date of this Agreement (or ten (10) calendar days after the Person becomes an Account Debtor) after the occurrence and during the continuance of an Event of Default, to send any and all
similar notices and directions to such Account Debtors, and (iii) shall do anything further that may be lawfully required by Lender to secure Lender and effectuate the intentions of the Loan Documents. 
  
 2.11 Power of Attorney 
  
 Lender is hereby irrevocably made, constituted and appointed the true and
lawful attorney for Borrower (without requiring any of them to act as such) with full power of substitution to do the following upon the occurrence and during the continuance of an Event of Default: (i) endorse the name of Borrower upon any and all
checks, drafts, money orders, and other instruments for the payment of money that are payable to Borrower and constitute collections on its Accounts; (ii) execute in the name of Borrower any financing statements, schedules, assignments, instruments,
documents, and statements that it is or they or are obligated to give Lender under any of the Loan Documents; and (iii) do such other and further acts and deeds in the name of Borrower that Lender may deem necessary or desirable to enforce any
Account or other Collateral or to perfect Lender’s security interest or lien in any Collateral. In addition, if Borrower breaches its obligation hereunder to direct payments of Accounts or the proceeds of any other Collateral to the appropriate
Lockbox Account, Lender, as the irrevocably made, constituted and appointed true and lawful attorney for Borrower pursuant to this paragraph, may, upon the occurrence and continuation of an Event of Default by the signature or other act of any of
Lender’s officers or authorized signatories (without requiring any of them to do so), direct any federal, state or private payor or fiscal intermediary to pay proceeds of Accounts or any other Collateral to the appropriate Lockbox Account.

  
 III. FEES AND OTHER CHARGES; ALLOCATION OF PURCHASE PRICE 

 
 3.1 Commitment Fee 
  
 On or before the Closing Date, Borrower shall pay to Lender 1.0% of
$4,000,000 as a nonrefundable commitment fee, which fee Lender acknowledges has been paid. On or before the date of this Agreement, Borrower shall pay to Lender 1.0% of $2,000,000 as a non-refundable commitment fee.  
  
 3.2 Unused Line Fee 
  
 Borrower shall pay to Lender an unused line fee (the “Unused Line
Fee”) in an amount equal to 0.042% (per month, prorated for partial months where this Agreement is only effective for a portion of any such month) of the difference derived by subtracting (i) the daily average amount of the balances under
the Revolving Facility outstanding during the preceding month, from (ii) the Facility Cap. The Unused Line Fee shall be payable monthly in arrears on the first Business Day of each successive calendar month (starting with the month in which the
Closing Date occurs). 
  

 7 

 3.3 Collateral Management Fee 
  
 Borrower shall pay Lender as additional interest a monthly collateral management fee (the “Collateral Management
Fee”) equal to 0.10% of the daily average amount of the balances under the Revolving Facility outstanding during the preceding month. The Collateral Management Fee shall be payable monthly in arrears on the first Business Day of each
successive calendar month (starting with the month in which the Closing Date occurs). 
  
 3.4 Early Termination Fees 
  
 If (i) Borrower terminates the Revolving Facility under Section 11.1 hereof, (ii) Lender demands upon the occurrence of an Event of Default or Borrower is otherwise required to make payment in full of the Revolving Facility and/or
Obligations relating to the Revolving Facility upon the occurrence of an Event of Default, (iii) a voluntary or involuntary Change of Control occurs, (iv) any prepayment of the Revolving Facility and/or Obligations occurs (other than reductions to
zero of the outstanding balance of the Revolving Facility resulting from the ordinary course operation of the provisions of Section 2.5), whether by virtue of Lender’s exercising its right of set-off or otherwise, or (v) any acceleration
of the Obligations or cessation of lending and termination of the commitment to lend occurs as a result of or during a bankruptcy, reorganization or other proceeding or liquidation or pursuant to any Debtor Relief Law (a “termination”),
then, at the effective date of any such termination, Borrower shall pay Lender (in addition to the then outstanding principal, accrued interest and other Obligations relating to the Revolving Facility pursuant to the terms of this Agreement and any
other Loan Document), as yield maintenance for the loss of bargain and not as a penalty, an amount equal to the applicable Minimum Termination Fee. 
  
 3.5 Computation of Fees; Lawful Limits 
  
 All fees hereunder shall be computed on the basis of a year of 360 days and for the actual number of days elapsed in each calculation period, as
applicable. In no contingency or event whatsoever, whether by reason of acceleration or otherwise, shall the interest and other charges paid or agreed to be paid to Lender for the use, forbearance or detention of money hereunder exceed the maximum
rate permissible under applicable law which a court of competent jurisdiction shall, in a final determination, deem applicable hereto. If, due to any circumstance whatsoever, fulfillment of any provision hereof, at the time performance of such
provision shall be due, shall exceed any such limit, then, the obligation to be so fulfilled shall be reduced to such lawful limit, and, if Lender shall have received interest or any other charges of any kind which might be deemed to be interest
under applicable law in excess of the maximum lawful rate, then such excess shall be applied first to any unpaid fees and charges hereunder, then to unpaid principal balance owed by Borrower hereunder, and if the then remaining excess interest is
greater than the previously unpaid principal balance, Lender shall promptly refund such excess amount to Borrower and the provisions hereof shall be deemed amended to provide for such permissible rate. The terms and provisions of this Section
3.5 shall control to the extent any other provision of any Loan Document is inconsistent herewith. 
  
 3.6 Default Rate of Interest 
  
 Upon the occurrence and during the continuation of an Event of Default, the Applicable Rate of interest in effect at such time with respect to the
Obligations shall be increased by 3.0% per annum (the “Default Rate”). 
  

 8 

 3.7 Acknowledgement of Joint and Several Liability 
  
 Each Borrower acknowledges that it is jointly and severally liable for all
of the Obligations under the Loan Documents. Each Borrower expressly understands, agrees and acknowledges that (i) Borrowers are all affiliated entities by common ownership, (ii) each Borrower desires to have the availability of one common credit
facility instead of separate credit facilities, (iii) each Borrower has requested that Lender extend such a common credit facility on the terms herein provided, (iv) Lender will be lending against, and relying on a lien upon, all of the Collateral
even though the proceeds of any particular loan made hereunder may not be advanced directly to a particular Borrower, (v) each Borrower will nonetheless benefit by the making of all such loans by Lender and the availability of a single credit
facility of a size greater than each could independently warrant, and (vi) all of the representations, warranties, covenants, obligations, conditions, agreements and other terms contained in the Loan Documents shall be applicable to and shall be
binding upon each Borrower. 
  
 IV. CONDITIONS PRECEDENT 
  
 4.1 Conditions to Initial Advance and Closing 
  
 The obligations of Lender to consummate the transactions contemplated herein
and to make the initial Advance under the Revolving Facility (the “Initial Advance”) are subject to the satisfaction of the following, all of which Lender acknowledges have been satisfied: 
  
 (a) Borrower shall have delivered to Lender (A) the Loan Documents to which
it is a party, each duly executed by an authorized officer of Borrower and in case of the Lockbox Agreement, executed by Harris Trust and Savings Bank, and (B) a Borrowing Certificate for the Initial Advance under the Revolving Facility executed by
an authorized officer of Borrower; 
  
 (b) all in form and
substance satisfactory to Lender in its sole discretion, Lender shall have received (i) a report of Uniform Commercial Code financing statement, tax and judgment lien searches performed with respect to Borrower in each jurisdiction determined by
Lender in its sole discretion, and such report shall show no Liens on the Collateral (other than Permitted Liens), (ii) each document (including, without limitation, any UCC financing statement) required by any Loan Document or under law or
reasonably requested by Lender to be filed, registered or recorded to create in favor of Lender, a perfected first priority security interest (subject to Permitted Liens, which in no case shall include or permit liens on Accounts or proceeds
thereof) upon the Collateral, and (iii) evidence of each such filing, registration or recordation and of the payment by Borrower (or by Lender on Borrower’s behalf) of any necessary fee, tax or expense relating thereto; 
  
 (c) Lender shall have received (i) the Charter and Good Standing Documents,
all in form and substance acceptable to Lender, (ii) a certificate of the corporate secretary or assistant secretary of Borrower dated the Closing Date, as to the incumbency and signature of the Persons executing the Loan Documents, in form and
substance acceptable to Lender, (iii) the written legal opinion of counsel for Borrower, in form and substance satisfactory to Lender and its counsel; and (iv) a certificate executed by an authorized officer of Borrower, which shall constitute a
representation and warranty by such Borrower as of the Closing Date and the applicable Borrowing Date that the conditions contained in this Agreement have been satisfied; 
  

 9 

 (d) Lender shall have received a certificate of the chief financial officer (or, in the absence of a
chief financial officer, the chief executive officer) of Borrower, in form and substance satisfactory to Lender (each, a “Solvency Certificate”), certifying (i) the solvency of Borrower after giving effect to the transactions and
the Indebtedness contemplated by the Loan Documents, and (ii) as to Borrower’s financial resources and ability to meet its obligations and liabilities as they become due, to the effect that as of the Closing Date and the Borrowing Date for the
Initial Advance and after giving effect to such transactions and Indebtedness: (A) the assets of Borrower, at a Fair Valuation, exceed the total liabilities (including contingent, subordinated, unmatured and unliquidated liabilities) of Borrower,
and (B) no unreasonably small capital base with which to engage in its anticipated business exists with respect to Borrower; 
  
 (e) Lender shall have completed examinations, the results of which shall be satisfactory in form and substance to Lender, of the Collateral, the financial
statements and the books, records, business, obligations, financial condition and operational state of Borrower, and Borrower shall have demonstrated to Lender’s satisfaction that (i) its operations comply, in all respects deemed material by
Lender, in its sole judgment, with all applicable federal, state, foreign and local laws, statutes and regulations, (ii) its operations are not the subject of any governmental investigation, evaluation or any remedial action which could result in
any expenditure or liability deemed material by Lender, in its sole judgment, and (iii) it has no liability (whether contingent or otherwise) that is deemed material by Lender, in its sole judgment; 
  
 (f) Lender shall have received all fees, charges and expenses payable to
Lender on or prior to the Closing Date pursuant to the Loan Documents; 
  
 (g) all in form and substance satisfactory to Lender in its sole discretion, Lender shall have received such consents, approvals and agreements, including, without limitation, any applicable Landlord Waivers and Consents with respect to any
and all leases at locations where Borrower maintains its financial and corporate books and records, as specified on Schedule 5.4, which may be delivered post-closing, as set forth on Schedule 6.8 hereto, from such third parties as
Lender and its counsel shall determine are necessary or desirable with respect to (i) the Loan Documents and/or the transactions contemplated thereby, and/or (ii) claims against Borrower or the Collateral; 
  
 (h) Borrower shall be in compliance with Section 6.5, and Lender shall
have received (i) certified copies of all such insurance policies, and (ii) original certificates of such insurance policies confirming that they are in effect and that the premiums due and owing with respect thereto have been paid in full;

  
 (i) all corporate and other proceedings, documents,
instruments and other legal matters in connection with the transactions contemplated by the Loan Documents (including, but not limited to, those relating to corporate and capital structures of Borrower) shall be satisfactory to Lender; and

  
 (j) Lender shall have received a signed IRS Form 8821 for each
Borrower and such other documents, certificates, information or legal opinions as Lender may reasonably request, all in form and substance reasonably satisfactory to Lender, which shall be delivered post-closing, as set forth on Schedule 6.8
hereto within the time therein provided. 
  

 10 

 4.2 Conditions to Each Advance 
  
 The obligations of Lender to make any Advance (including, without limitation, the Initial Advance) are subject to the
satisfaction of the following additional conditions precedent: 
  
 (a) Borrower shall have delivered to Lender a Borrowing Certificate for the Advance executed by an authorized officer of Borrower, which shall constitute a representation and warranty by Borrower as of the Borrowing Date of such Advance
that the conditions contained in this Section 4.2 have been satisfied; 
  
 (b) each of the representation and warranties made by Borrower in or pursuant to this Agreement shall be accurate, before and after giving effect to such Advance, as if made on the date of such Advance notwithstanding
any provision in Section V hereof limiting representations or warranties to the Closing Date or the date hereof, and no Default or Event of Default shall have occurred or be continuing or would exist after giving effect to the Advance under
the Revolving Facility on such date; 
  
 (c) immediately after
giving effect to the requested Advance, the aggregate outstanding principal amount of Advances under the Revolving Facility shall not exceed the lesser of the Availability and the Facility Cap; 
  
 (d) except as disclosed in the historical financial statements, there shall
be no liabilities or obligations with respect to Borrower of any nature whatsoever which, either individually or in the aggregate, would reasonably be likely to have a Material Adverse Effect; and 
  
 (e) Lender shall have received all fees, charges and expenses due and payable
to Lender on or prior to such date pursuant to the Loan Documents. 
  
 4.3 Conditions to This Agreement 
  
 The
obligations of Lender to enter into this Agreement are subject to the satisfaction of the following additional conditions precedent: 
  
 (a) Borrower shall have delivered to Lender an additional Note representing the increased Facility Cap executed by an authorized officer of Borrower;

  
 (b) Lender shall have received a signed IRS Form 8821 for each
Borrower in form and substance reasonably satisfactory to Lender; 
  
 (c) Lender shall have received certificates of insurance evidencing the designation of Lender as loss payee and additional insured in accordance with Section 6.5 hereto, which shall be delivered post-closing as set forth in
Schedule 6.8 hereto within the time therein provided; 
  
 (d) Lender shall have received a certificate of the corporate secretary or assistant secretary of Borrower dated the date hereof, as to the incumbency and signature of the Persons executing this Agreement and any other Loan Documents to be
executed in connection herewith, in form and substance acceptable to Lender, that there has been no change in the Borrower’s charter documents provided on the Closing Date, and certifying all resolutions necessary or appropriate from each
Borrower approving the transactions contemplated hereby; and 
  

 11 

 (e) Lender shall have received all fees, charges and expenses payable to Lender on or prior to the date
hereof pursuant to the Loan Documents. 
  
 V. REPRESENTATIONS AND WARRANTIES

  
 Borrower, jointly and severally, represents and warrants
as of the date hereof, and each Borrowing Date as follows: 
  
 5.1 Organization and Authority 
  
 Borrower is a
corporation duly organized, validly existing and in good standing, except as set forth on Schedule 5.1, under the laws of its state of formation. Borrower (i) has all requisite corporate power and authority to own its properties and assets
and to carry on its business as now being conducted and as contemplated in the Loan Documents, (ii) is duly qualified to do business in every jurisdiction in which failure so to qualify could reasonably be expected to have a Material Adverse Effect,
and (iii) has all requisite power and authority (A) to execute, deliver and perform the Loan Documents to which it is a party, (B) to borrow hereunder, (C) to consummate the transactions contemplated under the Loan Documents, and (D) to grant the
Liens with regard to the Collateral pursuant to the Security Documents to which it is a party. Borrower is not an “investment company” registered or required to be registered under the Investment Company Act of 1940, as amended, or
controlled by such an “investment company.” 
  
 5.2
Loan Documents 
  
 The execution, delivery and performance by
Borrower of the Loan Documents to which it is a party, and the consummation of the transactions contemplated thereby, (i) have been duly authorized by all requisite action of Borrower and have been duly executed and delivered by or on behalf of
Borrower; (ii) do not violate any provisions of (A) applicable law, statute, rule, regulation, ordinance or tariff, (B) any order of any Governmental Authority binding on Borrower or any of its properties, or (C) the certificate of incorporation or
bylaws (or any other equivalent governing agreement or document) of Borrower, or any agreement between Borrower and its respective stockholders; (iii) are not in conflict with, and do not result in a breach or default of or constitute an event of
default, or an event, fact, condition or circumstance which, with notice or passage of time, or both, would constitute or result in a conflict, breach, default or event of default under, any indenture, agreement or other instrument to which Borrower
is a party, or by which the properties or assets of Borrower are bound, the effect of which could reasonably be expected to have a Material Adverse Effect; (iv) except as set forth therein, will not result in the creation or imposition of any Lien
of any nature upon any of the properties or assets of Borrower, and (v) except as set forth on Schedule 5.2, do not require the consent, approval or authorization of, or filing, registration or qualification with, any Governmental Authority
or any other Person. When executed and delivered, each of the Loan Documents to which Borrower is a party will constitute the legal, valid and binding obligation of Borrower, enforceable against Borrower in accordance with its terms, subject to the
effect of any applicable bankruptcy, moratorium, insolvency, reorganization or other similar law affecting the enforceability of creditors’ rights generally and to the effect of general principles of equity which may limit the availability of
equitable remedies (whether in a proceeding at law or in equity). 
  

 12 

 5.3 Subsidiaries, Capitalization and Ownership Interests 
  
 Borrower has no Subsidiaries other than as set forth on Schedule 5.3.
Schedule 5.3 states as of the date hereof, the authorized and issued capitalization of Borrower, the number and class of equity securities issued and outstanding of Borrower and the record owners of two percent (2%) or more in the aggregate
of all such equity interests of Borrower (including options, warrants and other rights to acquire any of the foregoing). The outstanding equity securities of Borrower have been duly authorized and validly issued and are fully paid and nonassessable.
Schedule 5.3 also lists the directors and officers of Borrower. Except as listed on Schedule 5.3, Borrower does not own an interest or participate or engage in any joint venture, partnership or similar arrangements with any Person.

  
 5.4 Properties 
  
 Borrower (i) is the sole owner and has good, valid and marketable title to,
or a valid leasehold interest in, all of its properties and assets, including the Collateral, whether personal or real, subject to no transfer restrictions or Liens of any kind except for Permitted Liens, and (ii) is in compliance in all material
respects with each lease to which it is a party or otherwise bound. Schedule 5.4 lists all real properties (and their locations) owned or leased by or to, and all other material assets or property that are leased or licensed by, Borrower and
all leases covering or with respect to such properties and material assets as of the date hereof. Borrower enjoys peaceful and undisturbed possession under all such leases and such leases are all the leases necessary for the operation of such
properties and assets, are valid and subsisting and are in full force and effect.  
  
 5.5 Other Agreements 
  
 Except as set forth on Schedule 5.5, Borrower is not (i) a party to any judgment, order or decree or any agreement, document or instrument, or subject to any restriction, which would materially adversely affect its ability to execute
and deliver, or perform under, any Loan Document or to pay the Obligations and (ii) in default in the performance, observance or fulfillment of any obligation, covenant or condition contained in any agreement, document or instrument to which it is a
party or to which any of its properties or assets are subject, which default, if not remedied within any applicable grace or cure period could reasonably be expected to have a Material Adverse Effect, nor is there any event, fact, condition or
circumstance which, with notice or passage of time or both, would constitute or result in a conflict, breach, default or event of default under, any of the foregoing which, if not remedied within any applicable grace or cure period could reasonably
be expected to have a Material Adverse Effect. 
  
 5.6
Litigation 
  
 Except as set forth on Schedule 5.6,
there is no action, suit, proceeding or investigation pending or, to its knowledge, threatened against Borrower that (i) questions or could reasonably be expected to prevent the validity of any of the Loan Documents or the right of Borrower to enter
into any Loan Document or to consummate the transactions contemplated thereby, (ii) could reasonably be expected to be or have, either individually or in the aggregate, any Material Adverse Change or Material Adverse Effect, or (iii) could
reasonably be expected to result in any Change of Control. Borrower is not a party or subject to any order, writ, injunction, judgment or decree of any Governmental Authority that could reasonably be expected to have a Material Adverse Effect. As of
the Closing Date, there is no action, suit, proceeding or investigation initiated by Borrower pending. As of the Closing Date, Borrower does not have any existing accrued and/or unpaid Indebtedness to any Governmental Authority. 
  

 13 

 5.7 Hazardous Materials 
  
 Borrower is in compliance in all material respects with all applicable Environmental Laws. Borrower has not been notified of
any action, suit, proceeding or investigation (i) relating in any way to failure to comply by or liability of Borrower under any Environmental Laws, or (ii) which seeks to suspend, revoke or terminate any license, permit or approval of Borrower
necessary for the generation, handling, storage, treatment or disposal of any Hazardous Substance. 
  
 5.8 Potential Tax Liability; Tax Returns; Governmental Reports 
  
 (a) Except as disclosed in Schedule 5.8, Borrower (i) has not received any written communication from the Internal
Revenue Service with respect to any investigation or assessment relating to the Borrower directly, or relating to any consolidated tax return which was filed on behalf of Borrower, (ii) is not aware of any year more than five years past which
remains open pending tax examination or audit by the IRS, and (iii) is not aware of any information that could reasonably be expected to give rise to an IRS tax investigation or assessment. 
  
 (b) Borrower (i) has filed all federal, state, foreign (if applicable) and
local tax returns and other reports which are required by law to be filed by Borrower, and (ii) has paid all taxes, assessments, fees and other governmental charges, including, without limitation, payroll and other employment related taxes, in each
case that are due and payable, except only for items that Borrower is currently contesting in good faith and that are described on Schedule 5.8. 
  
 5.9 Financial Statements and Reports 
  
 All financial statements and financial information relating to Borrower that have been or may hereafter be delivered to Lender by Borrower are accurate
and complete and have been prepared in accordance with GAAP consistently applied with prior periods. Borrower has no material obligations or liabilities of any kind not disclosed in such financial information or statements that are required to be so
disclosed by GAAP consistently applied, and since the date of the most recent financial statements submitted to Lender, there has not occurred any Material Adverse Change or Material Adverse Effect or, to Borrower’s knowledge, any other event
or condition that could reasonably be expected to have a Material Adverse Effect. 
  
 5.10 Compliance with Law 
  
 Borrower (i) is in compliance with all laws, statutes, rules, regulations, ordinances and tariffs of any Governmental Authority applicable to Borrower and/or Borrower’s business, assets or operations, including, without limitation,
applicable requirements of the Standards for Privacy of Individually Identifiable Health Information which were promulgated pursuant to the Health Insurance Portability and Accountability Act of 1996 (“HIPAA”) and ERISA, and (ii) is not in
violation of any order of any Governmental Authority or other board or tribunal, except in each case where noncompliance or violation could not reasonably be expected to have a Material Adverse Effect. There is no event, fact, condition or
circumstance which, with notice or passage of time, or both, would constitute or result in any noncompliance with, or any violation of, any of the foregoing, in each case except where noncompliance or violation could not reasonably be expected to
have a Material Adverse Effect. Borrower has not received any notice that Borrower is not in compliance in any respect with any of the requirements of any of the foregoing. Borrower has (a) not engaged in any Prohibited Transactions as defined in
Section 406 of ERISA and Section 4975 of the Internal Revenue Code of 
  

 14 

 1986, as amended, and the rules and regulations promulgated thereunder, (b) not failed to meet any applicable minimum
funding requirements under Section 302 of ERISA in respect of its plans and no funding requirements have been postponed or delayed, (c) no knowledge of any amounts due but unpaid to the Pension Benefit Guaranty Corporation, or of any event or
occurrence which would cause the Pension Benefit Guaranty Corporation to institute proceedings under Title IV of ERISA to terminate any of the employee benefit plans, (d) no fiduciary responsibility under ERISA for investments with respect to any
plan existing for the benefit of Persons other than its employees or former employees, or (e) not withdrawn, completely or partially, from any multi-employer pension plans so as to incur liability under the MultiEmployer Pension Plan Amendments of
1980. With respect to Borrower, there exists no event described in Section 4043 of ERISA, excluding Subsections 4043(b)(2) and 4043(b)(3) thereof, for which the thirty (30) day notice period contained in 12 C.F.R. § 2615.3 has not been waived.
Borrower has maintained in all material respects all records required to be maintained by it by the Food and Drug Administration, Drug Enforcement Agency and State Boards of Pharmacy with jurisdiction over Borrower. 
  
 5.11 Intellectual Property 
  
 Except as set forth on Schedule 5.11 as of the date hereof, Borrower
does not own, license or utilize, and is not a party to, any patents, patent applications, trademarks, trademark applications, service marks, registered copyrights, copyright applications, copyrights, trade names, trade secrets, software or licenses
(collectively, the “Intellectual Property”). Borrower has advised Lender in writing of any additional registered copyrights it owns. 
  
 5.12 Licenses and Permits; Labor 
  
 Borrower is in compliance with and has all Permits and Intellectual Property necessary or required by applicable law or Governmental Authority for the
operation of its businesses. All of the foregoing are in full force and effect and not in known conflict with the rights of others. Borrower is not (i) in breach of or default under the provisions of any of the foregoing, nor is there any event,
fact, condition or circumstance which, with notice or passage of time or both, would constitute or result in a conflict, breach, default or event of default under, any of the foregoing which, if not remedied within any applicable grace or cure
period could reasonably be expected to have a Material Adverse Effect, (ii) a party to or subject to any agreement, instrument or restriction that is so unusual or burdensome that it could reasonably be expected to have a Material Adverse Effect,
and/or (ii) and has not been, involved in any labor dispute, strike, walkout or union organization which could reasonably be expected to have a Material Adverse Effect 
  
 5.13 No Default 
  
 There does not exist any Default or Event of Default or any event, fact, condition or circumstance which, with the giving of notice or passage of time or
both, would constitute or result in a Default or Event of Default. 
  
 5.14 Disclosure 
  
 No Loan Document nor any
other agreement, document, certificate, or statement furnished to Lender by or on behalf of Borrower in connection with the transactions contemplated by the Loan Documents, nor any representation or warranty made by Borrower in any Loan Document,
contains 
  

 15 

 any untrue statement of material fact or omits to state any fact necessary to make the statements therein not materially
misleading. There is no fact known to Borrower which has not been disclosed to Lender which Borrower reasonably believes is likely to have a Material Adverse Effect. 
  
 5.15 Existing Indebtedness; Investments, Guarantees and Certain Contracts 
  
 Except for Permitted Indebtedness, as contemplated by the Loan Document or
as otherwise set forth on Schedule 5.15, Borrower (i) has no outstanding Indebtedness, (ii) is not subject or party to any mortgage, note, indenture, indemnity or guarantee of, with respect to or evidencing any Indebtedness of any other
Person, and (iii) does not own or hold any equity or long-term debt investments in, and does not have any outstanding advances to or any outstanding guarantees for the obligations of, or any outstanding borrowings from, any Person. Borrower has
performed all material obligations required to be performed by Borrower pursuant to or connection with any items listed on Schedule 5.15 and there has occurred no breach, default or event of default under any document evidencing any such
items with respect to Indebtedness in excess of $100,000 or any fact, circumstance, condition or event which, with the giving of notice or passage of time or both, would constitute or result in a breach, default or event of default thereunder.

  
 5.16 Agreements Concerning Officers, Directors, Competitors

  
 Except as set forth on Schedule 5.16, (i) there
are no existing or proposed agreements, arrangements, understandings or transactions between Borrower and any of Borrower’s officers, directors (solely as of the date hereof with respect to directors who also perform clinical research), or 5%
stockholders or Affiliates or any members of their respective immediate families, and (ii) none of the foregoing Persons are directly or indirectly, indebted to or have any direct or indirect ownership, partnership or voting interest in, to
Borrower’s knowledge, any Person with which Borrower has a business relationship or which competes with Borrower (except that any such Persons may own stock in (but not exceeding two (2%) percent of the outstanding capital stock of) any
publicly traded company that may compete with Borrower). 
  
 5.17 Insurance 
  
 Borrower has in full force and
effect such insurance policies as are customary and appropriate in the judgment of management of the Company for its business and as may be required pursuant to Section 6.5 hereof. All such insurance policies as of the date hereof are listed
and described on Schedule 5.17. 
  
 5.18 Names; Location
of Offices, Records and Collateral 
  
 During the preceding
four years, Borrower has not conducted business under or used any name (whether corporate, partnership or assumed) other than as shown on Schedule 5.18A. To the best knowledge of Borrower, Borrower is the sole owner of all of its names listed
on Schedule 5.18A, and any and all business done and invoices issued in such names are Borrower’s sales, business and invoices. Each trade name of Borrower represents a division or trading style of Borrower. Borrower maintains its
principal places of business and chief executive office only at the locations set forth on Schedule 5.18B, and all Accounts of Borrower arise, originate and are located, and all of the Collateral other than Deposit Accounts and all books and
records in connection therewith or in any way relating thereto or evidence the Collateral other than Deposit Accounts are located and unless Borrower provides at least 30 calendar 
  

 16 

 days advance notice shall be only, in and at such locations, except for Equipment and Inventory with an estimated net
book value not to exceed $50,000 located at physician offices and other employee, agent or representative locations. All of the Collateral other than Deposit Accounts is located only in the United States. 
  
 5.19 Non-Subordination 
  
 The Obligations are not contractually subordinated in any way to any other
obligations of Borrower or to the rights of any other Person. 
  
 5.20 Accounts 
  
 In determining which Accounts
are Eligible Receivables, Lender may rely on all statements and representations made by Borrower with respect to any Account. Unless otherwise indicated in writing to Lender, each Account of Borrower (i) is genuine and in all respects what is
purports to be and is not evidenced by a judgment, (ii) arises out of a completed, bona fide sale and delivery of goods or rendering of Services by Borrower in the ordinary course of business and in accordance with the terms and conditions of all
purchase orders, contracts, certifications, participations, certificates of need and other documents relating thereto or forming a part of the contract between Borrower and the Account Debtor, (iii) is for a liquidated amount maturing as stated in a
claim or invoice covering such sale of goods or rendering of Services, a copy of which has been furnished or is available to Lender, (iv) together with Lender’s security interest therein, is not and will not be in the future (by voluntary act
or omission by Borrower), subject to any material offset, lien, deduction, defense, dispute, counterclaim or other adverse condition (other than in the ordinary course of business), is absolutely owing to Borrower and is not contingent in any
respect or for any reason, (v) there are no facts, events or occurrences which in any material way impair the validity or enforceability thereof or tend to reduce the amount payable thereunder from the face amount of the claim or invoice and
statements delivered to Lender with respect thereto, (vi) to the best of Borrower’s knowledge, (A) the Account Debtor thereunder had the capacity to contract at the time any contract or other document giving rise thereto was executed and (B)
such Account Debtor is solvent, (vii) to Borrower’s knowledge, there are no proceedings or actions which are threatened or pending against any Account Debtor under any Account which is reasonably expected to (A) be material and adverse to the
business, operations, properties, assets, liabilities or financial condition of such Account Debtor or (B) materially impair the ability and likelihood of such Account Debtor to pay such Eligible Receivables in full, and (viii) has been billed and
forwarded to the Account Debtor for payment in accordance with applicable laws and is in compliance and conformance with any requisite procedures, requirements and regulations governing payment by such Account Debtor with respect to such Account.

  
 5.21 Healthcare 
  
 Without limiting or being limited by any other provision of any Loan
Document, Borrower has timely filed or caused to be filed all material reports of every kind required by law, agreement or otherwise necessary for the continued operation of its business. There are no claims, actions or appeals pending (and Borrower
has not filed any claims or reports which could reasonably result in any such claims, actions or appeals) before any commission, board or agency or other Governmental Authority except such as could not reasonably be expected to result in a Material
Adverse Effect. 
  

 17 

 5.22 Survival 
  
 Borrower makes the representations and warranties contained herein with the knowledge and intention that Lender is relying
and will rely thereon. All such representations and warranties will survive the execution and delivery of this Agreement, and the making of the Advances under the Revolving Facility. 
  
 VI. AFFIRMATIVE COVENANTS 
  
 Each Borrower, jointly and severally, covenants and agrees that, until full performance and satisfaction, and indefeasible payment in full in cash, of all
the Obligations and termination of this Agreement: 
  
 6.1
Financial Statements, Reports and Other Information 
  
 (a)
Financial Reports. In addition to providing the Borrowing Certificate in accordance with Section 2.4, Borrower shall furnish to Lender (i) as soon as available and in any event within ninety (90) calendar days after the end of each
fiscal year of Borrower, audited annual consolidated financial statements of Borrower, including the notes thereto, consisting of a consolidated balance sheet at the end of such completed fiscal year and the related consolidated statements of
income, retained earnings, cash flows and owners’ equity for such completed fiscal year, which financial statements shall be prepared and certified without qualification, except for Borrower’s fiscal year 2001 audit, which may be
qualified, by an independent certified public accounting firm satisfactory to Lender and accompanied by related management letters, if available, and (ii) as soon as available and in any event within thirty (30) calendar days after the end of each
calendar month, unaudited consolidated and consolidating financial statements of Borrower consisting of a balance sheet and statements of income, retained earnings, cash flows and owners’ equity as of the end of the immediately preceding
calendar month. All such financial statements shall be prepared in accordance with GAAP consistently applied with prior periods. With each such financial statement, Borrower shall also deliver a certificate of its chief financial officer stating
that (A) such person has reviewed the relevant terms of the Loan Documents and the condition of Borrower, (B) no Default or Event of Default has occurred or is continuing, or, if any of the foregoing has occurred or is continuing, specifying the
nature and status and period of existence thereof and the steps taken or proposed to be taken with respect thereto, and (C) Borrower is in compliance with all financial covenants attached as Annex I hereto. Such certificate shall be accompanied by
the calculations necessary to show compliance with the financial covenants in a form satisfactory to Lender. 
  
 (b) Other Materials. Borrower shall furnish to Lender as soon as available, and in any event within ten (10) calendar days after the preparation or
issuance thereof or at such other time as set forth below: (i) copies of such financial statements (other than those required to be delivered pursuant to Section 6.1(a)) prepared by, for or on behalf of Borrower and any other notes, reports
and other materials related thereto, including, without limitation, any pro forma financial statements, (ii) any reports, returns, information, notices and other materials that relate to the material operations of the Borrower’s business that
Borrower sends to its stockholders, (iii) within thirty (30) calendar days after the end of each calendar month for such month, (A) a sales and collection report and accounts receivable and accounts payable aging schedule, including a report of
sales, credits issued and collections received, all such reports showing a reconciliation to the amounts reported in the monthly financial statements, and (C) a report listing ongoing clinical studies, (iv) promptly upon receipt thereof, copies of
any reports 
  

 18 

 submitted to Borrower by its independent accountants in connection with any interim audit of the books of Borrower and
copies of each management control letter provided by such independent accountants, and (v) such additional information, documents, statements, reports and other materials as Lender may reasonably request from a credit or security perspective or
otherwise from time to time. 
  
 (c) Notices. Borrower
shall promptly, and in any event within three (3) Business Days after Borrower or any authorized officer of Borrower obtains knowledge thereof, notify Lender in writing of (i) any pending or threatened litigation, suit, investigation, arbitration,
dispute resolution proceeding or administrative proceeding brought or initiated by Borrower or otherwise affecting or involving or relating to Borrower or any of its property or assets to the extent (A) the amount in controversy exceeds $100,000, or
(B) to the extent any of the foregoing seeks injunctive relief, (ii) any Default or Event of Default, which notice shall specify the nature and status thereof, the period of existence thereof and what action is proposed to be taken with respect
thereto, (iii) any other development, event, fact, circumstance or condition that could reasonably be expected to have a Material Adverse Effect, in each case describing the nature and status thereof and the action proposed to be taken with respect
thereto, (iv) any notice received by Borrower from any Account Debtor of a claim, suit or other action such Account Debtor has, claims or has filed against Borrower, which includes an amount in controversy in excess of $50,000, (v) any matter(s)
reasonably expected by Borrower to materially or adversely affect the value, enforceability or collectability of any of the (A) Account Collateral in existence at any one time, or (B) non-Account Collateral involving claims or disputes in the amount
of $40,000 or more, singly or in the aggregate, in existence at any one time, and (B) (vi) any notice given by Borrower to any other lender of Borrower and shall furnish to Lender a copy of such notice, (vii) receipt of any notice or request from
any Governmental Authority or governmental payor regarding any liability or claim of liability in excess of $100,000, (viii) the termination of any Key Officer, and/or (ix) if any Account becomes evidenced or secured by an Instrument or Chattel
Paper. 
  
 (d) Consents. Borrower shall obtain and deliver
from time to time all required consents, approvals and agreements from such third parties as Lender shall determine are necessary or desirable in its sole discretion and that are satisfactory to Lender with respect to (i) the Loan Documents and the
transactions contemplated thereby, and (ii) claims against Borrower or the Collateral, (iii) Landlord Waivers and Consents with respect to leases for locations identified by Borrower as those where corporate financial books and records are kept.

  
 (e) Operating Budget. Borrower shall furnish to Lender
on or prior to the Closing Date and for each fiscal year of Borrower prior to the commencement of such fiscal year, consolidated and consolidating month by month projected operating budgets, annual projections, profit and loss statements, balance
sheets and cash flow reports of and for Borrower for such upcoming fiscal year (including an income statement for each month and a balance sheet as at the end of the last month in each fiscal quarter), in each case prepared in accordance with GAAP
consistently applied with prior periods. 
  
 6.2 Payment of
Obligations 
  
 Borrower shall make full and timely
indefeasible payment in cash of the principal of and interest on the Loans, Advances and all other Obligations. 
  
 6.3 Conduct of Business and Maintenance of Existence and Assets 
  
 Borrower shall (i) conduct its business in accordance with good business practices customary to the industry, (ii) engage
principally in the same or similar lines of business substantially as 
  

 19 

 heretofore conducted, (iii) collect its Accounts in the ordinary course of business, (iv) maintain all of its material
properties, assets and equipment used or useful in its business in good repair, working order and condition (normal wear and tear excepted and except as may be disposed of in the ordinary course of business and in accordance with the terms of the
Loan Documents), (v) from time to time to make all necessary or desirable repairs, renewals and replacements thereof, (vi) maintain and keep in full force and effect its existence and all material Permits and qualifications to do business and good
standing in each jurisdiction in which the ownership or lease of property or the nature of its business makes such Permits or qualification necessary and in which failure to maintain such Permits or qualification could reasonably be likely to have a
Material Adverse Effect; and (vii) remain in good standing in Delaware and Illinois (to the extent Borrower currently conducts business in Illinois) and in all other jurisdictions in which currently located unless the failure to do so is not likely
to have a Material Adverse Effect. 
  
 6.4 Compliance with
Legal and Other Obligations 
  
 (a) Borrower shall (i) comply
with all material laws, statutes, rules, regulations, ordinances and tariffs of all Governmental Authorities applicable to it or its business, assets or operations, (ii) pay all taxes, assessments, fees, governmental charges, claims for labor,
supplies, rent and all other obligations or liabilities of any kind, except liabilities being contested in good faith and against which adequate reserves have been established, (iii) perform in accordance with its terms each contract, agreement or
other arrangement to which it is a party or by which it or any of the Collateral is bound, except where the failure to comply, pay or perform could not reasonably be expected to have a Material Adverse Effect, and (iv) maintain and comply with all
Permits necessary to conduct its business and comply with any new or additional requirements that may be imposed on it or its business. 
  
 (b) No later than January 1, 2005, Borrower shall provide evidence to Lender in form and substance and on terms satisfactory to Lender in its sole
discretion that a sufficient number of holders of the issued and outstanding AmericasDoctor, Inc. Series A-1, A-2, A-3, A-4, A-5, A-6 and A-7 preferred stock shall have waived their rights to, or otherwise agreed not to, redeem such preferred stock
until at least 90 days after the end of the Term such that the remaining number of non-waiving holders of such preferred stock does not satisfy the percentage requirement set forth in the certificates of designation, preferences and rights governing
the AmericasDoctor, Inc. Series A-1, A-2, A-3, A-4, A-5, A-6 and A-7 preferred stock necessary to require AmericasDoctor, Inc. to redeem such preferred stock. 
  

6.5 Insurance 
  
 Borrower shall (i) keep all of its insurable properties and assets adequately insured in all material respects against losses, damages and hazards as are
customarily insured against by businesses engaging in similar activities or owning similar assets or properties and at least the minimum amount required by applicable law, including, without limitation, medical malpractice and professional liability
insurance, as applicable; and shall maintain general public liability insurance at all times against liability on account of damage to persons and property having such limits, deductibles, exclusions and co-insurance and other provisions as are
customary for a business engaged in activities similar to those of Borrower; and (ii) maintain insurance under all applicable workers’ compensation laws; all of the foregoing insurance policies (A) to be reasonably satisfactory in form and
substance to Lender, and (B) solely with respect to general liability and property (and business interruption insurance, to the extent Borrower acquires such insurance) name Lender as loss payee and additional insured and expressly provide that they
cannot be altered, amended, modified or canceled without thirty (30) Business Days prior written notice to Lender and that they inure to the benefit of Lender notwithstanding any action or omission or negligence of or by Borrower or any insured
thereunder. Borrower shall give notice to Lender within two (2) Business Days of (i) receipt of any notice of cancellation of any of its current insurance policies or (ii) material change, for any reason, in the amounts of insurance coverage.

  

 20 

 6.6 True Books 
  
 Borrower shall (i) keep true, complete and accurate books of record and account in accordance with commercially reasonable
business practices in which true and correct entries are made of all of its and their dealings and transactions in all material respects; and (ii) set up and maintain on its books such reserves as may be required by GAAP with respect to doubtful
accounts and all taxes, assessments, charges, levies and claims and with respect to its business, and include such reserves in its quarterly as well as year end financial statements. 
  
 6.7 Inspection; Periodic Audits 
  
 Borrower shall permit the representatives of Lender, at the expense of Borrower, from time to time during normal business
hours upon reasonable notice, to (i) no more frequently than once per fiscal quarter at Borrower’s expense, unless a Default or Event of Default has occurred and is continuing, visit and inspect any of its offices or properties or any other
place where Collateral is located (except physician offices and other employee, agent or representative locations not owned or leased by Borrower where Equipment and Inventory may be kept) to inspect the Collateral and/or to examine or audit all of
its books of account, records, reports and other papers, (ii) make copies and extracts therefrom, and (iii) discuss its business, operations, prospects, properties, assets, liabilities, condition and/or Accounts with its officers and independent
public accountants (and by this provision such officers and accountants are authorized to discuss the foregoing). 
  
 6.8 Further Assurances; Post Closing 
  
 At Borrower’s cost and expense, Borrower shall (i) within five (5) Business Days after Lender’s demand, take such further actions, obtain such
consents and approvals and duly execute and deliver such further agreements, assignments, instructions or documents as Lender may reasonably request with respect to the purposes, terms and conditions of the Loan Documents and the consummation of the
transactions contemplated thereby, whether before, at or after the performance and/or consummation of the transactions contemplated hereby or the occurrence of a Default or Event of Default; (ii) without limiting and notwithstanding any other
provision of any Loan Document, execute and deliver, or cause to be executed and delivered, such agreements and documents, and take or cause to be taken such actions, and otherwise perform, observe and comply with such obligations, as are set forth
on Schedule 6.8; and (iii) upon the exercise by Lender or any of its Affiliates of any power, right, privilege or remedy pursuant to any Loan Document or under applicable law or at equity which requires any consent, approval, registration,
qualification or authorization of any Governmental Authority, execute and deliver, or cause the execution and delivery of, all applications, certificates, instruments and other documents that may be so required for such consent, approval,
registration, qualification or authorization. Without limiting the foregoing, upon the exercise by Lender or any of its Affiliates of any right or remedy under any Loan Document which requires any consent, approval or registration with, consent,
qualification or authorization by, any Person, Borrower shall execute and deliver, or cause the execution and delivery of, all applications, certificates, instruments and other documents that Lender or its Affiliate may be required to obtain for
such consent, approval, registration, qualification or authorization. 
  

 21 

 6.9 Payment of Indebtedness 
  
 Except as otherwise prescribed in the Loan Documents, Borrower shall pay, discharge or otherwise satisfy at or before
maturity (subject to applicable grace periods and, in the case of trade payables, to ordinary course payment practices) all of its material obligations and liabilities, except when the amount or validity thereof is being contested in good faith by
appropriate proceedings and such reserves as Lender may deem proper and necessary in its sole discretion shall have been made. 
  
 6.10 Lien Searches 
  
 If Liens other than Permitted Liens exist, Borrower immediately shall take, execute and deliver all actions, documents and instruments necessary to
release and terminate such Liens. 
  
 6.11 Use of
Proceeds 
  
 Borrower shall use the proceeds from the
Revolving Facility only for the purposes set forth in the second “WHEREAS” clause of this Agreement. 
  
 6.12 Collateral Documents; Security Interest in Collateral 
  
 Borrower shall (i) execute, obtain, deliver, file, register and/or record any and all financing statements, continuation
statements, stock powers, instruments and other documents, or cause the execution, filing, registration, recording or delivery of any and all of the foregoing, that are necessary or required under law or otherwise or reasonably requested by Lender
to be executed, filed, registered, obtained, delivered or recorded to create, maintain, perfect, preserve, validate or otherwise protect the pledge of the Collateral to Lender and Lender’s perfected first priority Lien on the Collateral (and
Borrower irrevocably grants Lender the right, at Lender’s option, to file any or all of the foregoing), (ii) immediately upon learning thereof, report to Lender any reclamation, return or repossession of goods in excess of $50,000 (individually
or in the aggregate), and (iii) defend the Collateral and Lender’s perfected first priority Lien thereon against all claims and demands of all Persons at any time claiming the same or any interest therein adverse to Lender, and pay all
reasonable costs and expenses (including, without limitation, in-house documentation and diligence fees and legal expenses and reasonable attorneys’ fees and expenses) in connection with such defense, which may at Lender’s discretion be
added to the Obligations. 
  
 6.13 Revisions to Schedules

  
 At any time after Closing, if there is any material
change in the matters set forth or required to be set forth on any Schedule annexed hereto, Borrower, with the prior consent of Lender, shall provide Lender with a revised Schedule to reflect such material differences. Borrower further agrees to
provide Lender at Lender’s request, but absent the occurrence or continuance of a Default or an Event of Default no more often than once every six months, an updated Schedule 5.16. 
  
 6.14 Taxes and Other Charges 
  
 (a) All payments and reimbursements to Lender made under any Loan Document
shall be free and clear of and without deduction for all taxes, levies, imposts, deductions, assessments, charges or withholdings, and all liabilities with respect thereto of any nature whatsoever, excluding taxes 
  

 22 

 to the extent imposed on Lender’s net income and franchise taxes imposed in lieu of taxes on net income. If Borrower
shall be required by law to deduct any such amounts from or in respect of any sum payable under any Loan Document to Lender, then the sum payable to Lender shall be increased as may be necessary so that, after making all required deductions, Lender
receives an amount equal to the sum it would have received had no such deductions been made. Notwithstanding any other provision of any Loan Document, if at any time after the Closing (i) any change in any existing law, regulation, treaty or
directive or in the interpretation or application thereof, (ii) any new law, regulation, treaty or directive enacted or any interpretation or application thereof, or (iii) compliance by Lender with any request or directive (whether or not having the
force of law) from any Governmental Authority: (A) subjects Lender to any tax, levy, impost, deduction, assessment, charge or withholding of any kind whatsoever with respect to any Loan Document, or changes the basis of taxation of payments to
Lender of any amount payable thereunder (except for net income taxes, or franchise taxes imposed in lieu of net income taxes, imposed generally by federal, state or local taxing authorities with respect to interest or commitment fees or other fees
payable hereunder or changes in the rate of tax on the overall net income of Lender), or (B) imposes on Lender any other condition or increased cost in connection with the transactions contemplated thereby or participations therein; and the result
of any of the foregoing is to increase the cost to Lender of making or continuing any Loan hereunder or to reduce any amount receivable hereunder, then, in any such case, Borrower shall promptly pay to Lender any additional amounts necessary to
compensate Lender, on an after-tax basis, for such additional cost or reduced amount as determined by Lender. If Lender becomes entitled to claim any additional amounts pursuant to this Section 6.14 it shall promptly notify Borrower of the
event by reason of which Lender has become so entitled, and each such notice of additional amounts payable pursuant to this Section 6.14 submitted by Lender to Borrower shall, absent manifest error, be final, conclusive and binding for all
purposes. Without limiting or being limited by any other provision of any Loan Document, Borrower at all times shall retain and use a Person acceptable to Lender to process, manage and pay its payroll taxes and shall cause to be delivered to Lender,
within ten (10) calendar days after such Person provides Borrower with a report and evidence of payment of such payroll taxes (which Borrower shall require such Person to deliver no less often than once per quarter), a copy of such report and
related evidence. 
  
 (b) Borrower shall promptly, and in any
event within five (5) Business Days after Borrower or any authorized officer of Borrower obtains knowledge thereof, notify Lender in writing of any oral or written communication from the Internal Revenue Service with respect to any (i) tax
investigations or assessments, relating to the Borrower directly, or relating to any consolidated tax return which was filed on behalf of Borrower, (ii) years more than five years past that are designated open pending tax examination or audit, and
(iii) information that could reasonably be expected to give rise to an IRS tax investigation or assessment. 
  
 VII. NEGATIVE COVENANTS 
  
 Each Borrower, jointly and severally, covenants and agrees that, until full performance and satisfaction, and indefeasible payment in full in cash, of all the Obligations and termination of this Agreement: 
  
 7.1 Financial Covenants 
  
 Borrower shall not violate the financial covenants set forth on Annex
I to this Agreement, which is incorporated herein and made a part hereof. 
  

 23 

 7.2 Permitted Indebtedness 
  
 Borrower shall not create, incur, assume or suffer to exist any Indebtedness, except the following (collectively,
“Permitted Indebtedness”): (i) Indebtedness under the Loan Documents, (ii) any Indebtedness set forth on Schedule 7.2, (iii) Capitalized Lease Obligations incurred after the Closing Date and Indebtedness incurred pursuant to
purchase money Liens permitted by Section 7.3(v), provided that the aggregate amount thereof outstanding at any time shall not exceed $500,000, (iv) Indebtedness in connection with advances made by a stockholder in order to cure any default
of the financial covenants set forth on Annex I; provided, however, that such Indebtedness shall be on an unsecured basis, subordinated in right of repayment and remedies to all of the Obligations and to all of Lender’s
rights and in form and substance satisfactory to Lender; (v) accounts payable to trade creditors and current operating expenses (other than for borrowed money) which are not aged more than 120 calendar days from the billing date or more than 30 days
from the due date (excluding accrued investigator fees), in each case incurred in the ordinary course of business and paid within such time period, unless the same are being contested in good faith and by appropriate and lawful proceedings and such
reserves, if any, with respect thereto as are required by GAAP and deemed adequate by Borrower’s independent accountants shall have been reserved; and (vi) Indebtedness incurred in the ordinary course of business and not exceeding $50,000
individually or in the aggregate outstanding at any one time; provided, however, that such Indebtedness shall be on an unsecured basis. Borrower shall not make any prepayment on any existing or future Indebtedness for money borrowed to
any Person other than to Lender or to the extent specifically permitted by this Agreement or any subsequent agreement between Borrower and Lender.  
  
 7.3 Permitted Liens 
  
 Borrower shall not create, incur, assume or suffer to exist any Lien upon, in or against, or pledge of, any of the Collateral or any of its properties or
assets or any of its shares, securities or other equity or ownership or partnership interests, whether now owned or hereafter acquired, except the following (collectively, “Permitted Liens”): (i) Liens under the Loan Documents or
otherwise arising in favor of Lender, (ii) Liens imposed by law for taxes, assessments or charges of any Governmental Authority for claims not yet due or which are being contested in good faith by appropriate proceedings and with respect to which
adequate reserves or other appropriate provisions are being maintained by Borrower in accordance with GAAP, (iii) (A) statutory Liens of landlords (provided that any landlord at a location where books and records are kept has executed a Landlord
Waiver and Consent in form and substance satisfactory to Lender) and of carriers, warehousemen, mechanics, materialmen, and (B) other Liens imposed by law or that arise by operation of law in the ordinary course of business from the date of creation
thereof, in each case only for amounts not yet due or which are being contested in good faith by appropriate proceedings and with respect to which adequate reserves or other appropriate provisions are being maintained by Borrower in accordance with
GAAP, (iv) Liens (A) incurred or deposits made in the ordinary course of business (including, without limitation, surety bonds and appeal bonds) in connection with workers’ compensation, unemployment insurance and other types of social security
benefits or to secure the performance of tenders, bids, leases, contracts (other than for the repayment of Indebtedness), statutory obligations and other similar obligations, or (B) arising as a result of progress payments under government
contracts, (v) purchase money Liens (A) securing Indebtedness permitted under Section 7.2(iii), or (B) in connection with the purchase by Borrower of inventory or equipment in the normal course of business, provided that such payables
shall not exceed any limits on Indebtedness provided for herein and shall otherwise be Permitted Indebtedness hereunder, (vi) Liens necessary and desirable for the operation of such Person’s business, provided Lender has consented to
such Liens in writing before their creation and existence; and (vii) Liens disclosed on Schedule 7.3. 
  

 24 

 7.4 Investments; New Facilities or Collateral; Subsidiaries 
  
 Borrower, directly or indirectly, shall not (a) purchase, own, hold, invest
in or otherwise acquire obligations or stock or securities of, or any other interest in, or all or substantially all of the assets of, any Person or any joint venture, or (b) make or permit to exist any loans, advances or guarantees to or for the
benefit of any Person or assume, guarantee, endorse, contingently agree to purchase or otherwise become liable for or upon or incur any obligation of any Person, other than: (i) those created by the Loan Documents; (ii) Permitted Indebtedness; (iii)
other investments which in the aggregate do not exceed $200,000 in any fiscal year of Borrower; and (iv) (A) trade credit extended in the ordinary course of business, (B) advances for business travel and similar temporary advances made in the
ordinary course of business to officers, directors and employees, and (C) the endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course of business. Borrower, directly or indirectly, shall not
purchase, own, operate, hold, invest in or otherwise acquire any facility, property or assets or any Collateral (other than Deposit Accounts) that is not located at the locations set forth on Schedule 5.18B or change its jurisdiction of
formation unless Borrower shall provide to Lender at least thirty (30) Business Days prior written notice. Except as set forth on Schedule 5.3, Borrower has no Subsidiaries. 
  
 7.5 Dividends; Redemptions 
  

Borrower shall not (i) declare, pay or make any dividend or distribution on any shares of capital stock or other securities or interests (other than
dividends or distributions payable in its stock, or split-ups or reclassifications of its stock), (ii) apply any of its funds, property or assets to the acquisition, redemption or other retirement of any capital stock or other securities or
interests or of any options to purchase or acquire any of the foregoing (provided, however, that Borrower may redeem its capital stock from terminated employees pursuant to, but only to the extent required under, the terms of the related employment
agreements as long as no Default or Event of Default has occurred and is continuing or would be caused by or result therefrom), (iii) otherwise make any payments or Distributions to any stockholder, member, partner or other equity owner in such
Person’s capacity as such, (iv) make any payment of any management or service fee to any Person (excluding payments for clinical trial services that are provided under arms-length contractual terms to physicians or entities affiliated with
investigative sites), other than payments made to Physician Partners from Excess Cash Flow which in the aggregate do not exceed 2.0% of Borrower’s revenues in any given fiscal year, provided, that Borrower shall not make any such Excess
Cash Flow payment if a Default or an Event of Default has occurred and is continuing or would result therefrom. 
  
 7.6 Transactions with Affiliates 
  
 Borrower shall not enter into or consummate any transaction of any kind with any of its Affiliates other than: (i) salary, bonus, employee stock option
and other compensation and employment arrangements with directors or officers in the ordinary course of business, provided, that no payment of any bonus shall be permitted if a Default or Event of Default has occurred and remains in effect or
would be caused by or result from such payment, (ii) Distributions and dividends permitted pursuant to Section 7.5, (iii) transactions on overall terms at least as favorable to Borrower as would be the case in an arm’s-length transaction
between unrelated parties of equal bargaining power, (iv) transactions with Lender or 
  

 25 

 any Affiliate of Lender, (v) payments permitted under and pursuant to written agreements entered into by and between
Borrower and one or more of its Affiliates that both (A) reflect and constitute transactions on overall terms at least as favorable to Borrower as would be the case in an arm’s-length transaction between unrelated parties of equal bargaining
power, and (B) are subject to such terms and conditions as determined by Lender in its sole discretion; provided, that notwithstanding the foregoing Borrower shall not (Y) enter into or consummate any transaction or agreement pursuant to
which it becomes a party to any mortgage, note, indenture or guarantee evidencing any Indebtedness of any of its Affiliates or otherwise to become responsible or liable, as a guarantor, surety or otherwise, pursuant to agreement for any Indebtedness
of any such Affiliate except for loans to employees in connection with the exercise of stock options or as set forth on Schedule 7.6, or (Z) make any cash payment (other than reimbursement of out of pocket expenses) to any of its Affiliates
(other than payments made in connection with the performance of clinical research related services) in excess of $100,000 in any given fiscal year without the prior written consent of Lender. 
  
 7.7 Charter Documents; Fiscal Year; Name; Jurisdiction of Organization;
Dissolution; Use of Proceeds 
  
 Borrower shall not (i)
amend, modify, restate or change its certificate of incorporation or bylaws in a manner that would be adverse to Lender, (ii) change its fiscal year unless Borrower demonstrates to Lender’s satisfaction compliance with the covenants contained
herein for both the fiscal year in effect prior to any change and the new fiscal year period by delivery to Lender of appropriate interim and annual pro forma, historical and current compliance certificates for such periods and such other
information as Lender may reasonably request, (iii) amend, alter or suspend or terminate or make provisional in any material way, any material Permit without the prior written consent of Lender, which consent shall not be unreasonably withheld, (iv)
wind up, liquidate or dissolve (voluntarily or involuntarily) or commence or suffer any proceedings seeking or that would result in any of the foregoing, (v) use any proceeds of any Advance for “purchasing” or “carrying”
“margin stock” as defined in Regulations U, T or X of the Board of Governors of the Federal Reserve System, or (vi) without at least 20 days prior written notice to Lender, change its name or change its jurisdiction of organization.

  
 7.8 Truth of Statements 
  
 Borrower shall not furnish to Lender any certificate or other document that
contains any untrue statement of a material fact or that omits to state a material fact necessary to make it not misleading in light of the circumstances under which it was furnished. 
  
 7.9 IRS Form 8821 
  
 Borrower shall not alter, amend, restate, or otherwise modify, or withdraw, terminate or re-file the IRS Form 8821 required to be filed by Lender.

  
 7.10 Transfer of Assets 
  
 Notwithstanding any other provision of this Agreement or any other Loan
Document, Borrower shall not, outside of the ordinary course of business, sell, lease, transfer, assign or otherwise dispose of any interest in any properties or assets (other than obsolete equipment or excess equipment no longer needed in the
conduct of the business in the ordinary course of business, or non-ordinary course of 
  

 26 

 business dispositions on arms length terms not to exceed $20,000 in any fiscal year), or agree to do any of the foregoing
at any future time, except that: 
  
 (a) Borrower may lease (as
lessee) real or personal property or surrender all or a portion of a lease of the same, in each case in the ordinary course of business (so long as such lease does not create or result in and is not otherwise a Capitalized Lease Obligation
prohibited under this Agreement); 
  
 (b) Borrower may license or
sublicense Intellectual Property or customer lists from or to third parties in the ordinary course of business, provided, that such licenses or sublicenses shall not interfere with the business or other operations of Borrower; and 

 
 (c) Borrower may consummate such other sales or dispositions of property
or assets (including any sale or transfer or disposition of all or any part of its assets and thereupon and within one year thereafter rent or lease the assets so sold or transferred) only to the extent prior written notice has been given to Lender
and to the extent Lender has given its prior written consent thereto, subject in each case to such conditions as may be set forth in such consent. 
  
 VIII. DEFAULT 
  
 8.1 Events of Default 
  
 The occurrence of any one or more of the following shall constitute an “Event of Default:” 
  
 (a) Borrower shall fail to pay any amount on the Obligations or provided for
in any Loan Document when due (whether on any payment date, at maturity, by reason of acceleration, by notice of intention to prepay, by required prepayment or otherwise); 
  
 (b) any representation, statement or warranty made or deemed made by Borrower in any Loan Document or in any other
certificate, document, report or opinion delivered in conjunction with any Loan Document to which it is a party, shall not be true and correct in all material respects or shall have been false or misleading in any material respect on the date when
made or deemed to have been made (except to the extent already qualified by materiality, in which case it shall be true and correct in all respects and shall not be false or misleading in any respect); 
  
 (c) Borrower shall be in violation, breach or default of, or shall fail to
perform, observe or comply with any covenant, obligation or agreement set forth in, any Loan Document and such violation, breach, default or failure shall not be cured within the applicable period set forth in the applicable Loan Document;
provided that, with respect to the affirmative covenants set forth in Article VI (other than Sections 6.1, 6.2, 6.3, 6.4(b), 6.5, 6.8, 6.9, and 6.11 for which there shall be no cure period) there shall be a thirty (30)
calendar day cure period commencing from the earlier of (i) Receipt by Borrower of written notice of such breach, default, violation or failure, and (ii) the time at which Borrower or any authorized officer thereof knew or became aware, or should
have known or been aware, of such failure, violation, breach or default, but Advances shall be made by Lender in its Permitted Discretion during the cure period; 
  
 (d) through action or inaction of Borrower (i) any of the Loan Documents ceases to be in full force and effect, or (ii) any
Lien created thereunder ceases to constitute a valid perfected first 
  

 27 

 priority (except with respect to Permitted Liens, which in no case shall include or permit liens on Accounts or proceeds
thereof) Lien on the Collateral in accordance with the terms thereof, or Lender ceases to have a valid perfected first priority (except with respect to Permitted Liens, which in no case shall include or permit liens on Accounts or proceeds thereof)
security interest in any of the Collateral or any securities pledged to Lender pursuant to the Security Documents; 
  
 (e) one or more tax assessments, judgments or decrees is rendered against Borrower in an amount in excess of $50,000 individually or $100,000 in the
aggregate, in excess of any applicable insurance coverage which is/are not satisfied, stayed, vacated or discharged of record within thirty (30) calendar days of being rendered, but Advances shall be made by Lender in its Permitted Discretion before
the judgment is stayed, vacated or discharged; 
  
 (f) any default
occurs, which is not cured or waived, (x) in the payment of any amount with respect to any Indebtedness (other than the Obligations) of Borrower in excess of $100,000, or (y) in the performance, observance or fulfillment of any provision contained
in any agreement, contract, document or instrument to which Borrower is a party or to which any of their properties or assets are subject or bound under or pursuant to which any Indebtedness in excess of $50,000 was issued, created, assumed,
guaranteed or secured in either case and such default continues for more than any applicable grace period or permits the holder of any Indebtedness to accelerate the maturity thereof; 
  
 (g) Borrower (i) shall be unable to pay its debts generally as they become due, (ii) shall file a petition seeking
protection under any insolvency statute or make a general assignment for the benefit of its creditors, (iii) shall commence a proceeding for the appointment of a receiver, trustee, liquidator or conservator of itself or of the whole or any
substantial part of its property, or (iv) shall file a petition seeking reorganization or liquidation or similar relief under any Debtor Relief Law or any other applicable law or statute; 
  
 (h) (i) a court of competent jurisdiction (A) shall enter an order, judgment or decree appointing a custodian, receiver,
trustee, liquidator or conservator of Borrower or the whole or any substantial part of any Borrower’s properties, which shall continue unstayed and in effect for a period of sixty (60) calendar days, (B) shall approve a petition filed against
Borrower seeking reorganization, liquidation or similar relief under the any Debtor Relief Law or any other applicable law or statute, which is not dismissed within sixty (60) calendar days, or (C) under the provisions of any Debtor Relief Law or
other applicable law or statute, assumes custody or control of Borrower or of the whole or any substantial part of any Borrower’s properties, which is not irrevocably relinquished within sixty (60) calendar days, or (ii) there is commenced
against Borrower any proceeding or petition seeking reorganization, liquidation or similar relief under any Debtor Relief Law or any other applicable law or statute, which (A) is not dismissed within sixty (60) calendar days after the date of
commencement, or (B) with respect to which Borrower takes any formal action to indicate its approval of or consent to any such proceeding or petition, but Advances shall be made by Lender in its Permitted Discretion before any such order, judgment
or decree described above is stayed, vacated or discharged, any such petition described above is dismissed, or any such custody or control described above is relinquished; 
  
 (i) (i) any Change of Control occurs or any agreement or commitment to cause or that may result in any such Change of
Control is entered into, (ii) any Material Adverse Effect, Material Adverse Change occurs, or (iii) Borrower ceases the conduct of a majority of its business operations as currently conducted or reasonably related thereto; 
  
 (j) Lender receives any evidence that Borrower may have directly or
indirectly been engaged in any type of activity which, in Lender’s reasonable judgment, could reasonably be expected to 
  

 28 

 result in forfeiture of any property with a fair market value in excess of $100,000 to any Governmental Authority which
shall have continued unremedied for a period of ten (10) calendar days after written notice from Lender (but Advances shall be made by Lender in its Permitted Discretion before any such activity ceases); 
  
 (k) an Event of Default occurs and is continuing beyond any cure period under
any other Loan Document; 
  
 (l) uninsured damage to, or loss,
theft or destruction of, any portion of the Collateral occurs that exceeds $100,000 in the aggregate in any single occurrence; 
  
 (m) Borrower or any of their respective directors or senior officers is criminally indicted or convicted under any law that could reasonably be expected
to lead to a forfeiture of any Collateral in excess of $100,000; 
  
 (n) the issuance of any process for levy, attachment or garnishment by any Government Authority not discharged or released within ten days and not in respect of taxes or Liens that related to taxes not yet due and payable or any other
Permitted Lien or execution upon or prior to any judgment against Borrower or any of its property or assets with a fair market value in excess of $100,000; or 
  

(o) Borrower does, or enters into or becomes a party to any agreement or commitment to do, or cause to be done, any of the things described in this
Article VIII or otherwise prohibited by any Loan Document (subject to any cure periods set forth therein); 
  
 8.2 Actions of Lender After Default; Certain Cure Rights 
  

In the event of any such Default or Event of Default, notwithstanding any other provision of any Loan Document, Lender may, by notice to Borrower (i)
terminate its obligations to make Advances hereunder, whereupon the same shall immediately terminate, (ii) declare the Note, all interest thereon and all other Obligations to be due and payable immediately (except in the case of an Event of Default
under Section 8(d), (g), (h) or (i)(iii), in which event all of the foregoing shall automatically and without further act by Lender be due and payable, provided that, with respect to non-material breaches or
violations that constitute Events of Default under clause (ii) of Section 8(d), there shall be a three (3) Business Day cure period (but no Advances will be made during any such cure period) commencing from the earlier of (A) Receipt by
Borrower of written notice of such breach or violation or of any event, fact or circumstance constituting or resulting in any of the foregoing, and (B) the time at which Borrower or any authorized officer thereof knew or became aware, or should have
known or been aware, of such breach or violation and resulting Event of Default or of any event, fact or circumstance constituting or resulting in any of the foregoing)), in each case without presentment, demand, protest or further notice of any
kind, all of which are hereby expressly waived by Borrower, and (iii) prohibit any action permitted to be taken under Article VII hereof. 
  

 29 

 IX. RIGHTS AND REMEDIES AFTER DEFAULT 
  
 9.1 Rights and Remedies 
  
 (a) In addition to the acceleration provisions set forth in Article VIII above, upon the occurrence and continuation of an Event of Default, Lender
shall have the right to exercise any and all rights, options and remedies provided for in any Loan Document, under the UCC or at law or in equity, including, without limitation, the right to (i) apply any property of Borrower held by Lender to
reduce the Obligations, (ii) foreclose the Liens created under the Security Documents, (iii) realize upon, take possession of and/or sell any Collateral or securities pledged with or without judicial process, (iv) exercise all rights and powers with
respect to the Collateral as Borrower, as applicable, might exercise, (v) collect and send notices regarding the Collateral, with or without judicial process, (vi) by its own means or with judicial assistance, enter any premises owned or leased by
Borrower at which Collateral and/or pledged securities are located, or render any of the foregoing unusable or dispose of the Collateral and/or pledged securities on such premises without any liability for rent, storage, utilities, or other sums,
and no Borrower shall resist or interfere with such action, (vii) at Borrower’s expense, require that all or any part of the Collateral be assembled and made available to Lender at any place designated by Lender, (viii) reduce or otherwise
change the Facility Cap, and/or (ix) relinquish or abandon any Collateral or securities pledged or any Lien thereon. Notwithstanding any provision of any Loan Document, Lender, in its sole discretion, shall have the right, at any time that Borrower
fails to do so, and from time to time, without prior notice, to the extent Borrower is required to do so or act hereunder, to: (i) obtain insurance covering any of the Collateral; (ii) pay for the performance of any of Obligations; (iii) discharge
taxes or Liens on any of the Collateral that are in violation of any Loan document unless Borrower is in good faith with due diligence by appropriate proceedings contesting those items; and (iv) pay for the maintenance and preservation of the
Collateral. Such expenses and advances shall be added to the Obligations until reimbursed to Lender and shall be secured by the Collateral, and such payments by Lender shall not be construed as a waiver by Lender of any Event of Default or any other
rights or remedies of Lender. 
  
 (b) Borrower agrees that notice
received by it at least ten (10) calendar days before the time of any intended public sale, or the time after which any private sale or other disposition of Collateral is to be made, shall be deemed to be reasonable notice of such sale or other
disposition. If permitted by applicable law, any perishable Collateral which threatens to speedily decline in value or which is sold on a recognized market may be sold immediately by Lender without prior notice to Borrower. At any sale or
disposition of Collateral or securities pledged, Lender may (to the extent permitted by applicable law) purchase all or any part thereof free from any right of redemption by Borrower which right is hereby waived and released. Borrower covenants and
agrees not to interfere with or impose any obstacle to Lender’s exercise of its rights and remedies under the UCC with respect to the Collateral. Lender, in dealing with or disposing of the Collateral or any part thereof, shall not be required
to give priority or preference to any item of Collateral or otherwise to marshal assets or to take possession or sell any Collateral with judicial process. 
  
 9.2 Application of Proceeds 
  
 In addition to any other rights, options and remedies Lender has under the Loan Documents, the UCC, at law or in equity, all dividends, interest, rents,
issues, profits, fees, revenues, income and other proceeds collected or received from collecting, holding, managing, renting, selling, or otherwise disposing of all or any part of the Collateral or any proceeds thereof upon exercise of its remedies
hereunder shall be applied in the following order of priority: (i) first, to the payment of all costs and expenses of such collection, storage, lease, holding, operation, management, sale, disposition or delivery and of conducting
Borrower’s business and of maintenance, repairs, replacements, alterations, additions and improvements of or to the Collateral, and to the payment of all sums which Lender may be required or may elect to pay, if any, for taxes, assessments,
insurance and other charges upon the 
  

 30 

 Collateral or any part thereof, and all other payments that Lender may be required or authorized to make under any
provision of this Agreement (including, without limitation, in each such case, in-house documentation and diligence fees and reasonable legal expenses, search, audit, recording, professional and filing fees and expenses and reasonable
attorneys’ fees and all expenses, liabilities and advances made or incurred in connection therewith); (ii) second, to the payment of all Obligations as provided herein; (iii) third, to the satisfaction of Indebtedness secured by
any subordinate security interest of record in the Collateral if written notification of demand therefor is received before distribution of the proceeds is completed, provided, that, if requested by Lender, the holder of a subordinate
security interest shall furnish reasonable proof of its interest, and unless it does so, Lender need not address its claims; and (iv) fourth, to the payment of any surplus then remaining to Borrower, unless otherwise provided by law or
directed by a court of competent jurisdiction, provided that Borrower shall be liable for any deficiency if such proceeds are insufficient to satisfy the Obligations or any of the other items referred to in this section. 
  
 9.3 Rights of Lender to Appoint Receiver 
  
 Without limiting and in addition to any other rights, options and remedies
Lender has under the Loan Documents, the UCC, at law or in equity, upon the occurrence and continuation of an Event of Default, Lender shall have the right to apply for and have a receiver appointed by a court of competent jurisdiction in any action
taken by Lender to enforce its rights and remedies in order to manage, protect and preserve the Collateral and continue the operation of the business of Borrower and to collect all revenues and profits thereof and apply the same to the payment of
all expenses and other charges of such receivership including the compensation of the receiver and to the payments as aforesaid until a sale or other disposition of such Collateral shall be finally made and consummated. 
  
 9.4 Rights and Remedies not Exclusive 
  
 Lender shall have the right in its sole discretion to determine which
rights, Liens and/or remedies Lender may at any time pursue, relinquish, subordinate or modify, and such determination will not in any way modify or affect any of Lender’s rights, Liens or remedies under any Loan Document, applicable law or
equity. The enumeration of any rights and remedies in any Loan Document is not intended to be exhaustive, and all rights and remedies of Lender described in any Loan Document are cumulative and are not alternative to or exclusive of any other rights
or remedies which Lender otherwise may have. The partial or complete exercise of any right or remedy shall not preclude any other further exercise of such or any other right or remedy. 
  
 X. WAIVERS AND JUDICIAL PROCEEDINGS 
  
 10.1 Waivers 
  
 Except as expressly provided for herein, Borrower hereby waives setoff, counterclaim, demand, presentment, protest and all defenses with respect to any
and all instruments and all notices and demands of any description. Borrower hereby waives any and all defenses and counterclaims it may have or could interpose in any action or procedure brought by Lender to obtain an order of court recognizing the
Lien of Lender in and to, any Collateral. With respect to any action hereunder, Lender conclusively may rely upon, and shall incur no liability to Borrower in acting upon, any request or other communication that Lender reasonably believes to have
been given or made by a person authorized on Borrower’s behalf, whether or not such person is listed on the incumbency certificate delivered pursuant to Section 4.1 hereof. In each such case, Borrower hereby waives the right to dispute
Lender’s action based upon such request or other communication, absent manifest error. 
  

 31 

 10.2 Delay; No Waiver of Defaults 
  
 No course of action or dealing, renewal, release or extension of any provision of any Loan Document, or single or partial
exercise of any such provision, or delay, failure or omission on Lender’s part in enforcing any such provision shall affect the liability of Borrower or operate as a waiver of such provision or affect the liability of Borrower or preclude any
other or further exercise of such provision. No waiver by any party to any Loan Document of any one or more defaults by any other party in the performance of any of the provisions of any Loan Document shall operate or be construed as a waiver of any
future default, whether of a like or different nature, and each such waiver shall be limited solely to the express terms and provisions of such waiver. Notwithstanding any other provision of any Loan Document, by completing the Closing under this
Agreement and/or by making Advances, Lender does not waive any breach of any representation or warranty of under any Loan Document, and all of Lender’s claims and rights resulting from any such breach or misrepresentation are specifically
reserved. 
  
 10.3 Jury Waiver 
  
 EACH PARTY TO THIS AGREEMENT HEREBY EXPRESSLY WAIVES ANY RIGHT TO TRIAL BY
JURY OF ANY CLAIM OR CAUSE OF ACTION ARISING UNDER THE LOAN DOCUMENTS OR IN ANY WAY CONNECTED WITH OR INCIDENTAL TO THE DEALINGS OF THE PARTIES WITH RESPECT TO THE LOAN DOCUMENTS OR THE TRANSACTIONS CONTEMPLATED THEREBY, WHETHER NOW EXISTING OR
HEREAFTER ARISING, AND WHETHER SOUNDING IN CONTRACT, TORT OR OTHERWISE. EACH PARTY HEREBY AGREES AND CONSENTS THAT ANY SUCH CLAIM OR CAUSE OF ACTION SHALL BE DECIDED BY COURT TRIAL WITHOUT A JURY, AND THAT ANY PARTY TO THIS AGREEMENT MAY FILE AN
ORIGINAL COUNTERPART OR A COPY OF THIS SECTION WITH ANY COURT AS WRITTEN EVIDENCE OF THE CONSENTS OF THE PARTIES TO THE WAIVER OF THEIR RESPECTIVE RIGHTS TO TRIAL BY JURY. 
  
 10.4 Right of First Refusal 
  

Intentionally omitted. 
  
 XI. EFFECTIVE DATE AND TERMINATION 
  
 11.1 Effectiveness and Termination 
  
 Subject to Lender’s right to terminate and cease making Advances upon or after any Event of Default, this Agreement shall continue in full force and
effect until the full performance and indefeasible payment in cash of all Obligations, unless terminated sooner as provided in this Section 11.1. Borrower may terminate this Agreement at any time upon not less than thirty (30) calendar
days’ prior written notice to Lender and upon full performance and indefeasible payment in full in cash of all Obligations on or prior to such 30th calendar day after Receipt by Lender of such written notice. All of the Obligations shall be immediately due and payable upon any such termination on the termination date stated in any notice of
termination (the “Termination Date”); provided that, notwithstanding any other provision of any Loan Document, the Termination Date shall be effective no 
  

 32 

 earlier than the first Business Day of the month following the expiration of the thirty (30) calendar days’ prior
written notice period. Notwithstanding any other provision of any Loan Document, no termination of this Agreement shall affect Lender’s rights or any of the Obligations existing as of the effective date of such termination, and the provisions
of the Loan Documents shall continue to be fully operative until the Obligations have been fully performed and indefeasibly paid in cash in full. The Liens granted to Lender under the Security Documents and the financing statements filed pursuant
thereto and the rights and powers of Lender shall continue in full force and effect notwithstanding the fact that Borrower’s borrowings hereunder may from time to time be in a zero or credit position until all of the Obligations have been fully
performed and indefeasibly paid in full in cash. 
  
 11.2
Survival 
  
 All obligations, covenants, agreements,
representations, warranties, waivers and indemnities made by Borrower in any Loan Document shall survive the execution and delivery of the Loan Documents, the Closing, the making of the Advances and any termination of this Agreement until all
Obligations are fully performed and indefeasibly paid in full in cash. The obligations and provisions of Sections 3.5, 3.6, 6.14(a), 10.1, 10.3, 11.1, 11.2, 12.1, 12.4, 12.5, 12.7 and 12.9 shall survive termination of the Loan Documents and
any payment, in full or in part, of the Obligations. 
  
 XII. MISCELLANEOUS

  
 12.1 Governing Law; Jurisdiction; Service of Process;
Venue 
  
 The Loan Documents shall be governed by and
construed in accordance with the internal laws of the State of Maryland without giving effect to its choice of law provisions. Any judicial proceeding against Borrower with respect to the Obligations, any Loan Document or any related agreement may
be brought in any federal or state court of competent jurisdiction located in the State of Maryland. By execution and delivery of each Loan Document to which it is a party, Borrower (i) accepts the non-exclusive jurisdiction of the aforesaid courts
and irrevocably agrees to be bound by any judgment rendered thereby, (ii) waives personal service of process, (iii) agrees that service of process upon it may be made by certified or registered mail, return receipt requested, pursuant to Section
12.5 hereof, (iv) waives any objection to jurisdiction and venue of any action instituted hereunder and agrees not to assert any defense based on lack of jurisdiction, venue or convenience, and (v) agrees that this loan was made in Maryland,
that Lender has accepted in Maryland Loan Documents executed by Borrower and has disbursed Advances under the Loan Documents in Maryland. Nothing shall affect the right of Lender to serve process in any manner permitted by law or shall limit the
right of Lender to bring proceedings against Borrower in the courts of any other jurisdiction having jurisdiction. Any judicial proceedings against Lender involving, directly or indirectly, the Obligations, any Loan Document or any related agreement
shall be brought only in a federal or state court located in the State of Maryland or the State of Delaware. All parties acknowledge that they participated in the negotiation and drafting of this Agreement and that, accordingly, no party shall move
or petition a court construing this Agreement to construe it more stringently against one party than against any other. 
  
 12.2 Successors and Assigns; Participations; New Lenders 
  

The Loan Documents shall inure to the benefit of Lender, Transferees and all future holders of any Note, the Obligations and/or any of the Collateral,
and each of their respective successors and assigns. Each Loan Document shall be binding upon the Persons’ other than Lender that are parties 
  

 33 

 thereto and their respective successors and assigns, and no such Person may assign, delegate or transfer any Loan
Document or any of its rights or obligations thereunder without the prior written consent of Lender. No rights are intended to be created under any Loan Document for the benefit of any third party donee, creditor or incidental beneficiary of
Borrower. Nothing contained in any Loan Document shall be construed as a delegation to Lender of any other Person’s duty of performance. BORROWER ACKNOWLEDGES AND AGREES THAT LENDER AT ANY TIME AND FROM TIME TO TIME MAY (I) DIVIDE AND RESTATE
ANY NOTE, AND/OR (II) SELL, ASSIGN OR GRANT PARTICIPATING INTERESTS IN OR TRANSFER ALL OR ANY PART OF ITS RIGHTS OR OBLIGATIONS UNDER ANY LOAN DOCUMENT, NOTE, THE OBLIGATIONS AND/OR THE COLLATERAL TO OTHER PERSONS (EACH SUCH TRANSFEREE, ASSIGNEE OR
PURCHASER, A “TRANSFEREE”), provided that all such assignments or transfers shall be in minimum amount of $500,000 or, if less, Lender’s entire interest under the Loan Documents and, provided
further, that any such transfer by Lender shall not be to a Person known by Lender to be a competitor of Borrower. Each Transferee shall have all of the rights and benefits with respect to the Obligations, Notes, Collateral and/or Loan
Documents held by it as fully as if the original holder thereof, and either Lender or any Transferee may be designated as the sole agent to manage the transactions and obligations contemplated therein; provided that, notwithstanding anything
to the contrary in any Loan Document, Borrower shall not be obligated to pay under this Agreement to any Transferee any sum in excess of the sum which Borrower would have been obligated to pay to Lender had such participation not been effected.
Notwithstanding any other provision of any Loan Document, Lender may disclose to any Transferee all information, reports, financial statements, certificates and documents obtained under any provision of any Loan Document. 
  
 12.3 Application of Payments 
  
 To the extent that any payment made or received with respect to the
Obligations is subsequently invalidated, determined to be fraudulent or preferential, set aside or required to be repaid to a trustee, debtor in possession, receiver, custodian or any other Person under any Debtor Relief Law, common law or equitable
cause or any other law, then the Obligations intended to be satisfied by such payment shall be revived and shall continue as if such payment had not been received by Lender. Any payments with respect to the Obligations received shall be credited and
applied in such manner and order as Lender shall decide in its sole discretion. 
  
 12.4 Indemnity 
  
 Each
Borrower, jointly and severally, shall indemnify Lender, its Affiliates and its and their respective managers, members, officers, employees, Affiliates, agents, representatives, successors, assigns, accountants and attorneys (collectively, the
“Indemnified Persons”) from and against any and all liabilities, obligations, losses, damages, penalties, actions, judgments, suits, costs, expenses and disbursements of any kind or nature whatsoever (including, without limitation,
reasonable fees and disbursements of counsel and in-house documentation and diligence fees and legal expenses) which may be imposed on, incurred by or asserted against any Indemnified Person other than Borrower with respect to or arising out of, or
in any litigation, proceeding or investigation instituted or conducted by any Person with respect to any aspect of, or any transaction contemplated by or referred to in, or any matter related to, any Loan Document or any agreement, document or
transaction contemplated thereby, whether or not such Indemnified Person is a party thereto, except to the extent that any of the foregoing arises out of the gross negligence or willful misconduct of such Indemnified Person or a claim of Borrower
finally determined by a court of competent jurisdiction in favor of Borrower. If any Indemnified Person uses in-house counsel for any purpose for which Borrower is responsible to pay or indemnify, Borrower 
  

 34 

 expressly agrees that its indemnification obligations include reasonable charges for such work commensurate with the fees
that would otherwise be charged by outside legal counsel selected by such Indemnified Person in its reasonable discretion for the work performed. Lender agrees to give Borrower reasonable notice of any event of which Lender becomes aware for which
indemnification may be required under this Section 12.4, and Lender may elect (but is not obligated) to direct the defense thereof, provided that the selection of counsel shall be subject to Borrower’s consent, which consent shall not be
unreasonably withheld or delayed. Any Indemnified Person may, in its reasonable discretion, take such actions as it deems necessary and appropriate to investigate, defend or, with Borrower’s written consent, which still not be unreasonably
withheld, settle any event or take other remedial or corrective actions with respect thereto as may be necessary for the protection of such Indemnified Person or the Collateral. Notwithstanding the foregoing, if any insurer agrees to undertake the
defense of an event (an “Insured Event”), Lender agrees not to exercise its right to select counsel to defend the event if that would cause Borrower’s insurer to deny coverage; provided, however, that Lender
reserves the right to retain counsel to represent any Indemnified Person with respect to an Insured Event at its sole cost and expense. To the extent that Lender obtains recovery from a third party other than an Indemnified Person of any of the
amounts that Borrower has paid to Lender pursuant to the indemnity set forth in this Section 12.4, then Lender shall promptly pay to such Borrower the amount of such recovery. 
  
 12.5 Notice 
  
 Any notice or request under any Loan Document shall be given to any party to this Agreement at such party’s address set forth beneath its signature
on the signature page to this Agreement, or at such other address as such party may hereafter specify in a notice given in the manner required under this Section 12.5. Any notice or request hereunder shall be given only by, and shall be
deemed to have been received upon (each, a “Receipt”): (i) registered or certified mail, return receipt requested, on the date on which such received as indicated in such return receipt, (ii) delivery by a nationally recognized
overnight courier, one (1) Business Day after deposit with such courier, or (iii) facsimile or electronic transmission, in each case upon telephone or further electronic communication from the recipient acknowledging receipt (whether automatic or
manual from recipient), as applicable. 
  
 12.6 Severability;
Captions; Counterparts; Facsimile Signatures 
  
 If any
provision of any Loan Document is adjudicated to be invalid under applicable laws or regulations, such provision shall be inapplicable to the extent of such invalidity without affecting the validity or enforceability of the remainder of the Loan
Documents which shall be given effect so far as possible. The captions in the Loan Documents are intended for convenience and reference only and shall not affect the meaning or interpretation of the Loan Documents. The Loan Documents may be executed
in one or more counterparts (which taken together, as applicable, shall constitute one and the same instrument) and by facsimile transmission, which facsimile signatures shall be considered original executed counterparts. Each party to this
Agreement agrees that it will be bound by its own facsimile signature and that it accepts the facsimile signature of each other party. 
  
 12.7 Expenses 
  
 Borrower shall pay, whether or not the Closing occurs, all costs and expenses incurred by Lender and/or its Affiliates, including, without limitation,
documentation and diligence fees and expenses, all search, audit, appraisal, recording, professional and filing fees and expenses and all other out-of-pocket charges and expenses (including, without limitation, UCC and judgment and tax lien

  

 35 

 searches and UCC filings and fees for post-Closing UCC and judgment and tax lien searches and wire transfer fees and
audit expenses), and reasonable attorneys’ fees and expenses, (i) in any effort to enforce, protect or collect payment of any Obligation or to enforce any Loan Document or any related agreement, document or instrument, (ii) in connection with
entering into, negotiating, preparing, reviewing and executing the Loan Documents and/or any related agreements, documents or instruments (which shall not exceed $50,000 without Lender’s prior notice to Borrower, (iii) arising in any way out of
administration of the Obligations, (iv) in connection with instituting, maintaining, preserving, enforcing and/or foreclosing on Lender’s Liens in any of the Collateral or securities pledged under the Loan Documents, whether through judicial
proceedings or otherwise, (v) in defending or prosecuting any actions, claims or proceedings arising out of or relating to Lender’s transactions with Borrower, (vi) in seeking, obtaining or receiving any advice with respect to its rights and
obligations under any Loan Document and any related agreement, document or instrument, and/or (vii) in connection with any modification, restatement, supplement, amendment, waiver or extension of any Loan Document and/or any related agreement,
document or instrument. To the extent incurred hereunder and not reimbursed promptly, all of the foregoing shall be charged to Borrower’s account and shall be part of the Obligations. If Lender or any of its Affiliates uses in-house counsel for
any purpose under any Loan Document for which Borrower is responsible to pay or indemnify, Borrower expressly agrees that its Obligations include reasonable charges for such work commensurate with the fees that would otherwise be charged by outside
legal counsel selected by Lender or such Affiliate in its sole discretion for the work performed. Without limiting the foregoing, Borrower shall pay all taxes (other than taxes based upon or measured by Lender’s income, franchise taxes in lieu
thereof, or revenues or any personal property tax), if any, in connection with the issuance of any Note and the filing and/or recording of any documents and/or financing statements. 
  
 12.8 Entire Agreement 
  
 This Agreement and the other Loan Documents to which Borrower is a party constitute the entire agreement between Borrower and Lender with respect to the
subject matter hereof and thereof, and supersede all prior agreements and understandings, if any, relating to the subject matter hereof or thereof. Any promises, representations, warranties or guarantees not herein contained and hereinafter made
shall have no force and effect unless in writing signed by Borrower and Lender. No provision of this Agreement may be changed, modified, amended, restated, waived, supplemented, discharged, canceled or terminated orally or by any course of dealing
or in any other manner other than by an agreement in writing signed by Lender and Borrower. Each party hereto acknowledges that it has been advised by counsel in connection with the negotiation and execution of this Agreement and is not relying upon
oral representations or statements inconsistent with the terms and provisions hereof. 
  
 12.9 Lender Approvals 
  
 Unless expressly provided herein to the contrary, any approval, consent, waiver or satisfaction of Lender with respect to any matter that is subject of any Loan Document may be granted or withheld by Lender in its sole and absolute
discretion. 
  
 12.10 Confidentiality and Publicity

  
 (a) Borrower agrees, and agrees to cause each of its
Affiliates, (i) not to transmit or disclose any provision of any Loan Document to any Person (other than to Borrower’s advisors and officers on a need-to-know basis) without Lender’s prior written consent, (ii) to inform all Persons of the

  

 36 

 confidential nature of the Loan Documents and to direct them not to disclose the same to any other Person and to require
each of them to be bound by these provisions. Lender reserves the right to review and approve all materials that Borrower or any of its Affiliates prepares that contain Lender’s name or describe or refer to any Loan Document, any of the terms
thereof or any of the transactions contemplated thereby. Borrower shall not, and shall not permit any of its Affiliates to, use Lender’s name (or the name of any of Lender’s Affiliates) in connection with any of its business operations.
Nothing in this paragraph shall condition or limit Borrower’s ability to disclose the Loan Documents in any filing with a governmental agency or in connection with its financial statements. Nothing contained in any Loan Document is intended to
permit or authorize Borrower or any of its Affiliates to contract on behalf of Lender. 
  
 (b) Lender agrees to keep confidential during the Term any material or information about Borrower that was delivered, disclosed, furnished or provided by Borrower or any agent, attorney or accountant of
Borrower to Lender and that was identified by Borrower or such other Person in writing as confidential (the “Confidential Information”). Confidential Information excludes material or information that is or becomes generally available to
the public or to any third party (other than Lender and its Representatives) than as a result of a breach by Lender hereof, or that was within the knowledge or possession of Lender or its Representatives (defined below) prior to being furnished by
Borrower or any agent, attorney or accountant of Borrower to Lender, or was or becomes available to Lender or its Representatives from a third party, or that was independently developed by Lender or its Representatives without reference to the
Confidential Information. Notwithstanding the foregoing or any other provision of this Agreement, Lender may disclose, provide and/or furnish Confidential Information: (a) to its officers, directors, partners, members, managers, stockholders,
controlling persons, affiliates, agents, advisors, representatives and employees, and any potential Transferee of the Loans (each, a “Representative”); and (b) otherwise pursuant to any of the following: (i) to any other person subject to
an obligation to maintain the confidentiality of such Confidential Information on substantially similar terms as those in this subsection, or (ii) if required by any governmental entity, law, regulation, governmental proceeding, court order or
similar process or otherwise, (iii) in connection with enforcing any agreement or rights between Borrower and Lender or defending any action or relating to the relationship between Lender and Borrower, and/or (iv) with respect to public or
non-confidential portions of such Confidential Information. Lender further agrees not to use Borrower’s name or logo in any written publication without Borrower’s prior consent, which shall not be unreasonably withheld or delayed.

  
 12.11 Amendment and Restatement 
  
 This Agreement and the Notes are given in amendment, consolidation,
restatement, renewal and extension (but not in novation, extinguishment or satisfaction) of the Loan Agreement and the promissory notes executed in connection therewith. All liens and security interests securing payment of the Obligations under the
Loan Agreement and such Loan Documents issued in connection therewith are hereby collectively renewed, extended, rearranged, ratified and brought forward as security for the payment and performance of the Obligations. With respect to matters
relating to the period prior to the date hereof, all of the provisions of the Loan Agreement and the promissory notes, security agreements, and other documents, instruments or agreements executed in connection therewith (including waivers granted by
Lender with respect thereto) are hereby ratified and confirmed and shall remain in force and effect. 
  
 [SIGNATURES APPEAR ON THE FOLLOWING PAGE] 
  

 37 

 IN WITNESS WHEREOF, each of the parties has duly executed this Revolving Credit Agreement as of the date
first written above. 
  

			
	AMERICASDOCTOR, INC.
		
	 By:
	 	 /s/ Dennis Cavender

	 Name:
	 	 Dennis Cavender

	 Its:
	 	 Chief Financial Officer

	
	AMERICASDOCTOR.COM COORDINATOR SERVICES, INC.
		
	 By:
	 	 /s/ Dennis Cavender

	 Name:
	 	 Dennis Cavender

	 Its:
	 	 Chief Financial Officer

	
	 Address for Borrower:

	 1325 Tri-State Parkway, Suite 300

	 Gurnee, IL 60031

	 Attention: Dennis Cavender

	 Telephone: (847) 855-7507

	 Fax: (847) 856-6207

	 E-Mail: dcavender@americasdoctor.com

  

 38 

  

			
	CAPITALSOURCE FINANCE LLC
		
	 By:
	 	 /s/ Keith D. Reuben

	 Name:
	 	 Keith D. Reuben

	 Its:
	 	 Chief Operating Officer

	
	 CapitalSource Finance LLC

	 4445 Willard Avenue, 12th Floor

	 Chevy Chase, MD 20815

	 Attention: Healthcare Finance Group, Portfolio Manager

	 Telephone: (301) 841-2700

	 FAX: (301) 841-2340

	 E-Mail: jheraty@capitalsource.com

  
  

 39 

					
	EXHIBITS
			
	 Exhibit A
	 	-	  	 Borrowing Certificate

	
	SCHEDULES
			
	 Schedule 2.4
	 	—	  	 Deposit Accounts

			
	 Schedule 5.1
	 	—	  	 Organization and Authority

			
	 Schedule 5.2
	 	—	  	 Consents

			
	 Schedule 5.3
	 	—	  	 Subsidiaries, Capitalization, and Ownership Interests

			
	 Schedule 5.4
	 	—	  	 Real and Material Personal Properties

			
	 Schedule 5.5
	 	—	  	 Other Agreements

			
	 Schedule 5.6
	 	—	  	 Litigation

			
	 Schedule 5.8
	 	—	  	 Tax Returns; Governmental Reports

			
	 Schedule 5.11
	 	—	  	 Intellectual Property

			
	 Schedule 5.15
	 	—	  	 Existing Indebtedness

			
	 Schedule 5.16
	 	—	  	 Other Agreements

			
	 Schedule 5.17
	 	—	  	 Insurance

			
	 Schedule 5.18A
	 	—	  	 Names

			
	 Schedule 5.18B
	 	—	  	 Location of Offices, Records and Collateral

			
	 Schedule 6.8
	 	—	  	 Further Assurances; Post Closing

			
	 Schedule 7.2
	 	—	  	 Permitted Indebtedness

			
	 Schedule 7.3
	 	—	  	 Permitted Liens

			
	 Schedule 7.6
	 	—	  	 Transactions with Affiliates

  

 1 

 Schedule 6.8 
 Further Assurances and Post Closing Deliverables 
  
 In accordance with and in furtherance of the provisions of Section 6.8 of the Agreement, the following actions, items and deliverables will be completed, taken and/or delivered to Lender’s satisfaction on
or before the date specified below. The failure to take, comply with or provide any of the actions or items referred to herein on or before such date shall constitute and be deemed an Event of Default under the Agreement. Nothing in this Schedule
6.8 shall limit the effect of any provision of the Agreement or Borrower’s obligations thereunder. Capitalized terms not otherwise defined in this Schedule 6.8 shall have the same meaning as in the Agreement. 
  

	 	1.	Insurance Certificates. No later than February 25, 2004, Borrower shall provide Lender with certificates of insurance evidencing the designation of Lender as loss
payee and additional insured in accordance with Section 6.5 hereto. 

  

 2 

 ANNEX I 
  
 FINANCIAL COVENANTS 
  
 1) Minimum Liquidity 
  
 At all times after February 1, 2004, Borrower on a consolidated basis shall not have less than the greater of (a) $500,000 of Available Cash or (b)
Available Cash in an amount equal to Borrower’s previous three (3) months of negative cash flow from operations. 
  
 2) Minimum EBITDA 
  
 At no time from August 1, 2004 through December 31, 2005, shall Borrower on a consolidated basis permit its EBITDA for the Test Period ending on the date
of such determination to be less than the amounts set forth below: 
  

				
	 Date of Determination

	 	Minimum EBITDA

	 July 31, 2004
	 	-$	1,147,000
	 August 31, 2004
	 	-$	1,142,000
	 September 30, 2004
	 	-$	1,101,000
	 October 31, 2004
	 	-$	1,227,000
	 November 30, 2004
	 	-$	1,328,000
	 December 31, 2004
	 	-$	1,404,000
	 January 31, 2005
	 	-$	1,347,000
	 February 28, 2005
	 	-$	1,455,000
	 March 31, 2005
	 	-$	1,560,000
	 April 30, 2005
	 	-$	1,428,000
	 May 31, 2005
	 	-$	1,274,000
	 June 30, 2005
	 	-$	1,179,000
	 July 31, 2005
	 	-$	 702,000
	 August 31, 2005
	 	-$	 224,000
	 September 30, 2005
	 	 $	207,000
	 October 31, 2005
	 	 $	411,000
	 November 30, 2005
	 	 $	616,000
	 December 31, 2005
	 	 $	820,000

  
 At no time from
January 31, 2006 through the end of the Term, shall Borrower, on a consolidated basis, permit its EBITDA for the Test Period ending on the date of such determination to be less than $820,000. 
  

 A 

 3) Fixed Charge Coverage Ratio (EBITDA/Fixed Charges) 
  
 From July 31, 2004 through September 30, 2005, at the end of each calendar
month, the Fixed Charge Coverage Ratio shall be a minimum of the ratio set forth below: 
  

			
	 Calendar Months

	  	Fixed Charge
Coverage Ratio

	 July and August 2004
	  	-5.0:1.0
	 September and October 2004
	  	-6.0:1.0
	 November and December 2004
	  	-7.0:1.0
	 January and February 2005
	  	-7.0:1.0
	 March and April 2005
	  	-6.0:1.0
	 May and June 2005
	  	-5.0:1.0
	 July 2005
	  	-3.0:1.0
	 August 2005
	  	-1.0:1.0
	 September 2005
	  	-0.5:1.0

  
 From October 31, 2005 through the end
of the Term, at the end of each calendar month, the Fixed Charge Coverage Ratio shall be a minimum of 1.2:1.0 
  
 4) Maximum Fixed Charges 
  
 At no time from August 1, 2004 until December 31, 2005, shall Borrower on a consolidated basis permit its Fixed Charges for the Test Period ending on the
date of such determination to exceed the amount set forth below: 
  

				
	 Date of Determination

	  	Maximum
Fixed Charges

	 July 31, 2004
	  	$	284,000
	 August 31, 2004
	  	$	299,000
	 September 30, 2004
	  	$	212,000
	 October 31, 2004
	  	$	235,000
	 November 30, 2004
	  	$	231,000
	 December 31, 2004
	  	$	257,000
	 January 31, 2005
	  	$	240,000
	 February 28, 2005
	  	$	265,000
	 March 31, 2005
	  	$	289,000
	 April 30, 2005
	  	$	303,000
	 May 31, 2005
	  	$	314,000
	 June 30, 2005
	  	$	322,000
	 July 31, 2005
	  	$	311,000
	 August 31, 2005
	  	$	300,000
	 September 30, 2005
	  	$	289,000
	 October 31, 2005
	  	$	292,000
	 November 30, 2005
	  	$	294,000
	 December 31, 2005
	  	$	296,000

  

 B 

 For purposes of the covenants set forth in this Annex I, the terms listed below shall have the following
meanings: 
  
 “Available Cash” shall mean, for
and on any date, the sum, without duplication, of the following for Borrower: (a) unrestricted cash on hand on such date, (b) Cash Equivalents held on such date, and (c) the unborrowed Availability on and as of such date. 
  
 “Cash Equivalents” shall mean (a) securities issued, or
directly and fully guaranteed or insured, by the United States or any agency or instrumentality thereof (provided that the full faith and credit of the United States is pledged in support thereof) having maturities of not more than six months from
the date of acquisition, (b) U.S. dollar denominated time deposits, certificates of deposit and bankers’ acceptances of (i) any domestic commercial bank of recognized standing having capital and surplus in excess of $100,000,000, or (ii) any
bank (or the parent company of such bank) whose short-term commercial paper rating from Standard & Poor’s Ratings Services (“S&P”) is at least A-2 or the equivalent thereof or from Moody’s Investors Service, Inc.
(“Moody’s”) is at least P-2 or the equivalent thereof in each case with maturities of not more than six months from the date of acquisition (any bank meeting the qualifications specified in clauses (b)(i) or (ii), an
“Approved Bank”), (c) repurchase obligations with a term of not more than seven days for underlying securities of the types described in clause (a), above, entered into with any Approved Bank, (d) commercial paper issued by any
Approved Bank or by the parent company of any Approved Bank and commercial paper issued by, or guaranteed by, any industrial or financial company with a short-term commercial paper rating of at least A-2 or the equivalent thereof by S&P or at
least P-2 or the equivalent thereof by Moody’s, or guaranteed by any industrial company with a long term unsecured debt rating of at least A or A2, or the equivalent of each thereof, from S&P or Moody’s, as the case may be, and in each
case maturing within six months after the date of acquisition and (e) investments in money market funds substantially all of whose assets are comprised of securities of the type described in clauses (a) through (d) above. 
  
 “CTMS/ASP Expenditures” shall mean expenses relating to
Borrower’s clinical trial management software and/or application service provider expenditures. 
  
 “EBITDA” shall mean, for any Test Period, the sum, without duplication, of the following for Borrower, on a consolidated basis: Net
Income determined in accordance with GAAP, plus, (a) Interest Expense, (b) taxes on income, whether paid, payable or accrued, (c) depreciation expense, (d) amortization expense, (e) all other non-cash, non-recurring charges and expenses,
excluding accruals for cash expenses made in the ordinary course of business, (f) loss from any sale of assets, other than sales in the ordinary course of business, and (g) for any calendar month relating to 2004, CTMS/ASP Expenditures for such
month determined to be operating expenses in accordance with GAAP, provided that all CTMS/ASP Expenditures incurred in calendar year 2004 shall not exceed $458,000; all of the foregoing determined in accordance with GAAP, minus (a) gains from any
sale of assets, other than sales in the ordinary course of business and (b) other extraordinary or non-recurring gains 
  
 “Fixed Charge Coverage Ratio” shall mean, for Borrower, on a consolidated basis, the ratio of (a) EBITDA for the Test Period to (b) Fixed
Charges for the Test Period. 
  
 “Fixed
Charges” shall mean, the sum of the following for the Test Period: (a) Total Debt Service, (b) Capital Expenditures, excluding for any calendar month relating to 2004, CTMS/ASP Expenditures for such month, provided that all CTMS/ASP
Expenditures incurred in calendar year 2004 shall not exceed $458,000, (c) income taxes paid in cash or accrued, and (d) dividends paid or accrued or declared. 
  

“Interest Expense” shall mean, for any Test Period, total interest expense (including attributable to Capital Leases in accordance
with GAAP) and fees with respect to all outstanding 
  

 C 

 Indebtedness including capitalized interest but excluding commissions, discounts and other fees owed with respect to
letters of credit and bankers’ acceptance financing and net costs under Interest Rate Agreements. 
  
 “Interest Rate Agreement” shall mean any interest rate swap, cap or collar agreement or other similar agreement or arrangement designed
to hedge the position with respect to interest rates. 
  
 “Net Income” shall mean, the net income (or loss) determined in conformity with GAAP, provided that there shall be excluded (i) the income (or loss) of any Person in which any other Person (other than any Borrower) has a
joint interest, except to the extent of the amount of dividends or other distributions actually paid to a Borrower by such Person, (ii) the income (or loss) of any Person accrued prior to the date it becomes a Borrower or is merged into or
consolidated with a Borrower or that Person’s assets are acquired by a Borrower, (iii) the income of any Subsidiary of Borrower to the extent that the declaration or payment of dividends or similar distributions of that income by that
Subsidiary is not at the time permitted by operation of the terms of the charter or any agreement, instrument, judgment, decree, order, statute, rule or governmental regulation applicable to that Subsidiary, (iv) compensation expense resulting from
the issuance of capital stock, stock options or stock appreciation rights issued to former or current employees, including officers, of a Borrower, or the exercise of such options or rights, in each case to the extent the obligation (if any)
associated therewith is not expected to be settled by the payment of cash by a Borrower or any affiliate thereof, and (v) compensation expense resulting from the repurchase of capital stock, options and rights described in clause (iv) of this
definition of Net Income. 
  
 “Test Period” shall
mean the six most recent calendar months then ended (taken as one accounting period). 
  
 “Total Debt Service” shall mean the sum of (i) scheduled or other required payments of principal on Indebtedness, and (ii) Interest Expense, in each case for the Test Period. 
  

 D 

 APPENDIX A 
  
 DEFINITIONS 
  
 “Accounts” shall mean all “accounts” (as defined in the UCC) of Borrower (or, if referring to another Person, of such other
Person), including without limitation, accounts, accounts receivables, monies due or to become due and obligations in any form (whether arising in connection with contracts, contract rights, instruments, general intangibles or chattel paper), in
each case whether arising out of goods sold or services rendered or from any other transaction and whether or not earned by performance, now or hereafter in existence, and all documents of title or other documents representing any of the foregoing,
and all collateral security and guaranties of any kind, now or hereafter in existence, given by any Person with respect to any of the foregoing. 
  
 “Account Debtor” shall mean any Person who is obligated under an Account. 
  
 “Advance” shall mean a borrowing under the Revolving Facility. Any amounts paid by Lender on behalf of
Borrower at Borrower’s request, or otherwise, under any Loan Document shall be an Advance for purposes of the Agreement. 
  
 “Affiliate” shall mean, as to any Person, any other Person (a) that, directly or indirectly through one or more intermediaries, controls,
is controlled by, or is under common control with, such Person, (b) who is a director or officer (i) of such Person, (ii) of any Subsidiary of such Person, or (iii) of any Person described in clause (a) above with respect to such Person, or (c)
which, directly or indirectly through one or more intermediaries, is the beneficial or record owner (as defined in Rule 13d-3 of the Securities Exchange Act of 1934, as amended, as the same is in effect on the date hereof) of ten percent (10%) or
more of any class of the outstanding voting stock, securities or other equity or ownership interests of such Person. For purposes of this definition, the term “control” (and the correlative terms, “controlled by” and “under
common control with”) shall mean the possession, directly or indirectly, of the power to direct or cause the direction of the management or policies, whether through ownership of securities or other interests, by contract or otherwise.

  
 “Applicable Rate” shall mean the interest
rates applicable from time to time to Advances under the Agreement. 
  
 “Borrowing Base” shall mean, as of any date of determination, the net collectible U.S. Dollar value of Eligible Receivables, as determined with reference to the most recent Borrowing Certificate and otherwise in accordance
with the Agreement; provided, however, that if as of such date the most recent Borrowing Certificate is of a date more than five (5) Business Days before or after such date, the Borrowing Base shall be determined by Lender in its sole
discretion. 
  
 “Borrowing Certificate” shall
mean a Borrowing Certificate substantially in the form of Exhibit A. 
  
 “Business Day” shall mean any day other than a Saturday, Sunday or other day on which the Federal Reserve or Lender is closed. 
  
 “Capital Expenditures” shall mean the sum (without duplication) of all expenditures (whether paid in cash
or accrued as liabilities) that are or should be treated as capital expenditures under GAAP, but excluding such expenditures financed by Permitted Indebtedness or other external sources of funds (such as insurance proceeds for lost or damaged
property). 

 “Capital Lease” shall mean, as to any Person, a lease of any interest in any kind of
property or asset by that Person as lessee that is, should be or should have been recorded as a “capital lease” in accordance with GAAP. 
  
 “Capitalized Lease Obligations” shall mean all obligations of any Person under Capital Leases, in each case, taken at the amount thereof
accounted for as a liability in accordance with GAAP. 
  
 “Change of Control” shall mean, with respect to Borrower, the occurrence of any of the following: (i) a merger, consolidation, reorganization, recapitalization or share or interest exchange, sale or transfer or any other
transaction or series of transactions in which its stockholders, managers, partners or interest holders immediately prior to such transaction or series of transactions receive, in exchange for the stock or interests owned by them, cash, property or
securities of the resulting or surviving entity or any Affiliate thereof, and, as a result thereof, Persons who, individually or in the aggregate, were holders of 50% or more of its voting stock, securities or equity, partnership or ownership
interests immediately prior to such transaction or series of transactions hold less than 50% of the voting stock, securities or other equity, partnership or ownership interests of the resulting or surviving entity or such Affiliate thereof,
calculated on a fully diluted basis, (ii) a direct or indirect sale, transfer or other conveyance or disposition, in any single transaction or series of related transactions, of all or substantially all of its assets. 
  
 “Charter and Good Standing Documents” shall mean, for
Borrower (i) a copy of the certificate of incorporation certified as of a date acceptable to Lender by the applicable Governmental Authority of the jurisdiction of incorporation or organization of such Borrower, (ii) a copy of the bylaws of Borrower
certified as of a date acceptable to Lender by the corporate secretary or assistant secretary of such Borrower, (iii) an original certificate of good standing as of a date acceptable to Lender issued by the applicable Governmental Authority of the
jurisdiction of incorporation or organization of such Borrower and of every other jurisdiction in which such Borrower is otherwise required to be in good standing, and (iv) copies of the resolutions of the Board of Directors and, if required,
stockholders, authorizing the execution, delivery and performance of the Loan Documents to which such Borrower is a party, certified by an authorized officer of such Person as of the Closing Date. 
  
 “Closing” shall mean the satisfaction, or written waiver by
Lender, of all of the conditions precedent set forth in the Agreement required to be satisfied prior to the consummation of the transactions contemplated hereby. 
  
 “Closing Date” shall mean March 15, 2002. 
  
 “Collateral” has the meaning ascribed to it in Section 2.9(a). 
  
 “Debtor Relief Law” shall mean, collectively, the Bankruptcy
Code of the United States of America and all other applicable liquidation, conservatorship, bankruptcy, moratorium, rearrangement, receivership, insolvency, reorganization or similar debtor relief laws from time to time in effect affecting the
rights of creditors generally, as amended from time to time. 
  
 “Default” shall mean any event, fact, circumstance or condition that, with the giving of applicable notice or passage of time or both, would constitute or be or result in an Event of Default. 
  
 “Deposit Account” shall mean, collectively, the Lockbox
Account and all bank or other depository accounts of Borrower. 

 “Distribution” shall mean any fee, payment, bonus or other remuneration of any kind, and
any repayment of or debt service on loans or other indebtedness. 
  
 “Eligible Receivables” shall mean each Account arising in the ordinary course of Borrower’s business from the rendering of Services unless: 
  
 (a) it is not subject to a valid perfected first priority security interest in favor of Lender, subject to no other Lien
(other than Permitted Liens, which in no case shall include or permit liens on Accounts or proceeds thereof; 
  
 (b) it arises out of services rendered or a sale made to, or out of any other transaction between with, one or more Affiliates (other than services
related to clinical research business) of Borrower; 
  
 (c) it
remains unpaid for longer than 180 calendar days after the applicable invoice date or Services were rendered; 
  
 (d) with respect to all Accounts owed by any particular Account Debtor and/or its Affiliates, 50% or more of all such Accounts are not deemed Eligible
Receivables for any reason hereunder (which percentage may, in Lender’s sole discretion, be increased or decreased); 
  
 (e) with respect to all Accounts owed by any particular Account Debtor and/or its Affiliates, if such Accounts exceed 20% of the Borrowing Base
provided, however, that Lender will consider lending against Accounts that exceed such 20% threshold on a case by case basis; 
  
 (f) any covenant, agreement, representation or warranty contained in any Loan Document with respect to such Account has been breached and remains uncured;

  
 (g) the Account Debtor for such Account has commenced a
voluntary case under any Debtor Relief Law or has made a general assignment for the benefit of creditors, or a decree or order for relief has been entered by a court having jurisdiction in respect of such Account Debtor in an involuntary case under
any Debtor Relief Law, or any other petition or application for relief under any Debtor Relief Law has been filed against such Account Debtor, or such Account Debtor has failed, suspended business, ceased to be solvent, or has consented to or
suffered a receiver, trustee, liquidator or custodian to be appointed for it or for all or a significant portion of its assets or affairs; 
  
 (h) it arises from the sale of property or services rendered to one or more Account Debtors outside the United States; 
  
 (i) it represents the sale of goods or rendering of services to an Account
Debtor on a bill-and-hold, guaranteed sale, sale-and-return, sale on approval, consignment or any other repurchase or return basis or is evidenced by chattel paper or an instrument of any kind or has been reduced to judgment; 
  
 (j) it is subject to any material offset, credit (including any resource or
other income credit or offset) deduction, defense, discount, chargeback, freight claim, allowance, adjustment, dispute or counterclaim, or is contingent in any respect or for any reason; 
  
 (k) there is any agreement with an Account Debtor for any material deduction from such Account, except for discounts or
allowances made in the ordinary course of business for prompt payment, all of which discounts or allowances are reflected in the calculation of the face value of each invoice related thereto, such that only the discounted amount of such Account
after giving effect to such discounts and allowances shall be considered an Eligible Receivable; 

 (l) any return, rejection or repossession of goods or services related to it has occurred; 
  
 (m) it is not payable to Borrower; 
  
 (n) Borrower has agreed to accept or has accepted any non-cash payment for
such Account; 
  
 (o) with respect to any Account arising from the
performance of Services, the Services have not been actually performed or the Services were undertaken in violation of any law; or 
  
 (p) it fails to meet such other specifications and requirements which may from time to time be established by Lender or is not otherwise satisfactory to
Lender, each as determined in Lender’s discretion in accordance with its customary business practices. 
  
 “Environmental Laws” shall mean, collectively and each individually, the Comprehensive Environmental Response, Compensation and Liability
Act of 1980, the Superfund Amendment and Reauthorization Act of 1986, the Resource Conservation and Recovery Act, the Toxic Substances Control Act, the Clean Air Act, the Clean Water Act, any other “Superfund” or “Superlien” law
and all other federal, state and local and foreign environmental, land use, zoning, health, chemical use, safety and sanitation laws, statutes, ordinances and codes relating to the protection of the environment and/or governing the use, storage,
treatment, generation, transportation, processing, handling, production or disposal of Hazardous Substances, in each case, as amended, and the rules, regulations, policies, guidelines, interpretations, decisions, orders and directives of
Governmental Authorities with respect thereto. 
  
 “ERISA” shall mean the Employee Retirement Income Security Act of 1974, as amended, and the regulations thereunder. 
  
 “Event of Default” shall mean the occurrence of any event set forth in Article VIII. 
  
 “Excess Cash Flow” shall mean, for any fiscal year, without
duplication, an amount equal to the sum of (i) consolidated net income or loss of Borrower for such period, plus (ii) an amount equal to the amount of depreciation expenses, amortization expense (including the amortization of goodwill),
accrued non cash interest expense and all other non cash charges deducted in arriving at such consolidated net income or loss, plus (iii) an amount equal to the aggregate net cash proceeds of the sale, lease, transfer or other disposition of
assets by Borrower during such period to the extent not required to be applied to mandatory prepayments or payments on the Loans, plus, (iv) an amount equal to the net loss on the sale, lease, transfer or other disposition of assets by
Borrower during such period to the extent deducted in arriving at such consolidated net income or loss, plus (v) without duplication with other items included in this definition other amount of any tax refunds or credits received by Borrower
during such period, less (vi) an amount equal to the permitted and used Capital Expenditures of Borrower for such period, less (vii) an amount equal to the sum of all regularly scheduled payments and optional and mandatory prepayments
of principal or Indebtedness for borrowed money of Borrower (other than on the Loans) actually made during such period to the extent permitted hereunder, less (viii) an amount equal to the net gain on the sale, lease, transfer or other
disposition of assets by Borrower during such period to the extent included in arriving at such consolidated net income or loss. 

 “Fair Valuation” shall mean the determination of the value of the consolidated assets of
a Person on the basis of the amount which may be realized by a willing seller within a reasonable time through collection or sale of such assets at market value on a going concern basis to an interested buyer who is willing to purchase under
ordinary selling conditions in an arm’s length transaction. 
  
 “GAAP” shall mean generally accepted accounting principles in the United States of America in effect from time to time as applied by nationally recognized accounting firms. 
  
 “Governmental Authority” shall mean any federal, state,
municipal, national, local or other governmental department, court, commission, board, bureau, agency or instrumentality or political subdivision thereof, or any entity or officer exercising executive, legislative or judicial, regulatory or
administrative functions of or pertaining to any government or any court, in each case, whether of the United States or a state, territory or possession thereof, a foreign sovereign entity or country or jurisdiction or the District of Columbia.

  
 “Hazardous Substances” shall mean, without
limitation, any flammable explosives, radon, radioactive materials, asbestos, urea formaldehyde foam insulation, polychlorinated biphenyls, petroleum and petroleum products, methane, hazardous materials, hazardous wastes, hazardous or toxic
substances or related materials as defined in or subject to any applicable Environmental Law. 
  
 “Indebtedness” of any Person shall mean, without duplication, (a) all items which, in accordance with GAAP, would be included in determining total liabilities as shown on the liability side of the
balance sheet of such Person as of the date as of which Indebtedness is to be determined, including any lease which, in accordance with GAAP would constitute Indebtedness, (b) all indebtedness secured by any mortgage, pledge, security, Lien or
conditional sale or other title retention agreement to which any property or asset owned or held by such Person is subject, whether or not the indebtedness secured thereby shall have been assumed, (c) all indebtedness of others which such Person has
directly or indirectly guaranteed (sold with recourse or agreed) to purchase or repurchase or otherwise acquire, or in respect of which such Person has agreed to supply or advance funds (whether by way of loan, stock, equity or other ownership
interest purchase, capital contribution or otherwise) or otherwise to become directly or indirectly liable. 
  
 “Key Officers” shall mean the chief executive officer, chief information officer, chief financial officers, vice president of sales, and
vice president of operations of Borrower. 
  
 “Landlord
Waiver and Consent” shall mean a waiver/consent in form and substance satisfactory to Lender from the owner/lessor of any premises not owned by Borrower at which any of its financial or corporate books and records are now or hereafter
located for the purpose of providing Lender access to such Collateral, in each case, as such may be modified, amended or supplemented from time to time. 
  
 “Lien” shall mean any mortgage, pledge, security interest, encumbrance, restriction, lien or charge of any kind (including any agreement
to give any of the foregoing, any conditional sale or other title retention agreement or any lease in the nature thereof), or any other arrangement pursuant to which title to the property is retained by or vested in some other Person for security
purposes. 
  
 “Loan” or “Loans”
shall mean, individually and collectively, all Advances under the Revolving Facility. 
  
 “Loan Documents” shall mean, collectively and each individually, the Agreement, the Note, the Security Documents, the Lockbox Agreements, the UCC financing statements, the Landlord 

 Waiver and Consents, the Borrowing Certificates, and all other agreements, documents, instruments and certificates
heretofore or hereafter executed or delivered to Lender in connection with any of the foregoing or the Loans, as the same may be amended, modified or supplemented from time to time. 
  
 “Lockbox Accounts” shall mean the accounts maintained by Borrower at the Lockbox Banks into which all
collections or payments on their Accounts and other Collateral are paid. 
  
 “Material Adverse Effect” or “Material Adverse Change” shall mean any event, condition or circumstance or set of events, conditions or circumstances or any change(s) which (i) has,
had or could reasonably be expected to have any material adverse effect upon or change in the validity or enforceability of any Loan Document, (ii) has been or could reasonably be expected to be material and adverse to the value of the Collateral as
a whole or to the business, operations, properties, assets, liabilities or financial condition of Borrower, either individually or taken as a whole, or (iii) has materially impaired or could reasonably be expected to materially impair the ability of
Borrower to perform the Obligations or to consummate the transactions under the Loan Documents executed by it. 
  
 “Minimum Termination Fee” shall mean an amount equal to 2.5% of the Facility Cap. 
  
 “Note” shall mean, each promissory note payable to the order
of Lender executed by Borrower evidencing the Revolving Facility, as the same may be modified, amended or supplemented from time to time. 
  
 “Obligations” shall mean all present and future obligations, Indebtedness and liabilities of Borrower to Lender at any time and from time
to time of every kind, nature and description, direct or indirect, secured or unsecured, joint and several, absolute or contingent, due or to become due, matured or unmatured, now existing or hereafter arising, contractual or tortious, liquidated or
unliquidated, under any of the Loan Documents or otherwise relating to the Note and/or Loans, including, without limitation, all applicable fees, charges and expenses and/or all amounts paid or advanced by Lender on behalf of or for the benefit of
Borrower for any reason at any time, including in each case obligations of performance as well as obligations of payment and interest that accrue after the commencement of any proceeding under any Debtor Relief Law by or against any such Person.

  
 “Payment Office” shall mean initially the
address set forth beneath Lender’s name on the signature page of the Agreement, and thereafter, such other office of Lender, if any, which it may designate by notice to Borrower to be the Payment Office. 
  
 “Permit” shall mean collectively all licenses, leases,
powers, permits, franchises, certificates, authorizations, approvals, certificates of need, provider numbers and other rights. 
  
 “Permitted Discretion” shall mean a determination or judgment made by Lender in good faith in the exercise of reasonable (from the
perspective of a secured lender) business judgment. 
  
 “Person” shall mean an individual, a partnership, a corporation, a limited liability company, a business trust, a joint stock company, a trust, an unincorporated association, a joint venture, a Governmental Authority or any
other entity of whatever nature. 
  
 “Physician
Partners” shall mean the physicians, and any entities affiliated therewith, that are parties to a contractual arrangement with Borrower relating to the provision of clinical trial services. 
  
 “Prime Rate” shall mean a fluctuating interest rate per
annum equal at all times to the rate of interest announced publicly from time to time by Citibank, N.A. as its base rate; provided, that 

 such rate is not necessarily the best rate offered to its customers, and, should Lender be unable to determine such rate,
such other indication of the prevailing prime rate of interest as may reasonably be chosen by Lender; provided, that each change in the fluctuating interest rate shall take effect simultaneously with the corresponding change in the Prime
Rate. 
  
 “Security Documents” shall mean the
Note, this Agreement, the Lockbox Agreements, UCC financing statements and all other documents or instruments necessary to create or perfect the Liens in the Collateral, as such may be modified, amended or supplemented from time to time. 

 
 “Services” shall mean the clinical research and data
management services provided by Borrower to pharmaceutical companies pursuant to clinical research study agreements. 
  
 “Subsidiary” shall mean, (i) as to Borrower, any Person in which more than 50% of all equity, membership, partnership or other ownership
interests is owned directly or indirectly by Borrower or one or more of its Subsidiaries, and (ii) as to any other Person, any Person in which more than 50% of all equity, membership, partnership or other ownership interests is owned directly or
indirectly by such Person or by one or more of such Person’s Subsidiaries. 
  
 “Term” shall mean the period commencing on the Closing Date and ending on February 20, 2007. 
  
 “UCC” shall mean the Uniform Commercial Code as in effect in the State of Maryland from time to time.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00063-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00063-of-00352.parquet"}]]